Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ubiquitin-like protein ligase activity	RNF144B IRF2BP1 RGPD1 ZZEF1 HERC2 MED7 SMURF2 PML RGPD2 TRIM58 PIAS2 RFWD3 TRIM45 UHRF1 LONRF2	1.52e-04	398	249	15	GO:0061659
GeneOntologyMolecularFunction	guanyl-nucleotide exchange factor activity	OBSCN PLEKHG5 RHOU DOCK5 HERC2 ARHGEF5 ARHGEF12 RAB3GAP1 ARHGEF1 KIAA1755 GDPGP1	1.61e-04	231	249	11	GO:0005085
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	RGPD1 OBSCN PLEKHG5 RHOU DOCK5 GBP5 HERC2 PLXNB1 RGPD2 ARHGEF5 ARHGEF12 TBC1D17 RAB3GAP1 ARHGEF1 KIAA1755 ARHGAP18 GDPGP1	2.26e-04	507	249	17	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	RGPD1 OBSCN PLEKHG5 RHOU DOCK5 GBP5 HERC2 PLXNB1 RGPD2 ARHGEF5 ARHGEF12 TBC1D17 RAB3GAP1 ARHGEF1 KIAA1755 ARHGAP18 GDPGP1	2.26e-04	507	249	17	GO:0030695
GeneOntologyMolecularFunction	ubiquitin-like protein transferase activity	RNF144B IRF2BP1 RGPD1 BCOR ZZEF1 HERC2 MED7 SMURF2 PML RGPD2 TRIM58 UBA3 PIAS2 RFWD3 TRIM45 UHRF1 LONRF2	2.53e-04	512	249	17	GO:0019787
GeneOntologyMolecularFunction	aminoacyltransferase activity	RNF144B IRF2BP1 RGPD1 BCOR ZZEF1 HERC2 MED7 SMURF2 PML RGPD2 TRIM58 UBA3 PIAS2 RFWD3 TRIM45 UHRF1 LONRF2	3.93e-04	532	249	17	GO:0016755
GeneOntologyCellularComponent	filopodium tip	VIL1 FZD3 OSBPL3 EPHB1	7.57e-05	20	244	4	GO:0032433
HumanPheno	Abnormal proportion of transitional B cells	PIK3CD PIK3R1 ARHGEF1	1.65e-05	4	83	3	HP:0030379
HumanPheno	Increased proportion of transitional B cells	PIK3CD PIK3R1 ARHGEF1	1.65e-05	4	83	3	HP:0030381
HumanPheno	Abnormal macroscopic urine appearance	OBSCN NUP205 ATP11C NUP160 NPHS1 ANKFY1 NUP93	3.63e-05	58	83	7	HP:0033072
MousePheno	increased plasmacytoid dendritic cell number	ITGAX PLD4 SIK3 ARHGEF1	2.58e-05	13	199	4	MP:0008524
MousePheno	increased Ly6C-positive NK T cell number	RHOBTB1 SIK3 ARHGEF1	2.78e-05	5	199	3	MP:0013679
Domain	TPR-like_helical_dom	SART3 TTC21A RGPD1 IFIT5 TTC4 TRRAP SMYD4 TOMM70 HELZ RGPD2 ST13P4 AAR2 LONRF2	1.32e-05	233	245	13	IPR011990
Domain	PHR	BTBD6 BTBD1 BTBD2	2.19e-05	5	245	3	IPR012983
Domain	PHR	BTBD6 BTBD1 BTBD2	2.19e-05	5	245	3	PF08005
Domain	-	CAND2 ARMC3 TRRAP ATXN10 BRAT1 ARMC7 RTTN RICTOR IPO4 SCYL2 HEATR6 AP4B1	3.87e-05	222	245	12	1.25.10.10
Domain	ARM-type_fold	CAND2 ARMC3 TRRAP DOCK5 PIK3CD USP35 ATXN10 BRAT1 ARMC7 RTTN RICTOR IPO4 SCYL2 HEATR6 AP4B1	4.43e-05	339	245	15	IPR016024
Domain	ARM-like	CAND2 ARMC3 TRRAP USP35 ATXN10 BRAT1 ARMC7 RTTN RICTOR IPO4 SCYL2 HEATR6 AP4B1	6.12e-05	270	245	13	IPR011989
Domain	Cadherin_CS	CDH23 PCDHGB7 PCDHGB6 CELSR1 CELSR3 CELSR2 DSG4 PCDH9	9.50e-05	109	245	8	IPR020894
Domain	CADHERIN_1	CDH23 PCDHGB7 PCDHGB6 CELSR1 CELSR3 CELSR2 DSG4 PCDH9	1.22e-04	113	245	8	PS00232
Domain	Cadherin	CDH23 PCDHGB7 PCDHGB6 CELSR1 CELSR3 CELSR2 DSG4 PCDH9	1.22e-04	113	245	8	PF00028
Domain	-	CDH23 PCDHGB7 PCDHGB6 CELSR1 CELSR3 CELSR2 DSG4 PCDH9	1.30e-04	114	245	8	2.60.40.60
Domain	CADHERIN_2	CDH23 PCDHGB7 PCDHGB6 CELSR1 CELSR3 CELSR2 DSG4 PCDH9	1.30e-04	114	245	8	PS50268
Domain	CA	CDH23 PCDHGB7 PCDHGB6 CELSR1 CELSR3 CELSR2 DSG4 PCDH9	1.38e-04	115	245	8	SM00112
Domain	Cadherin-like	CDH23 PCDHGB7 PCDHGB6 CELSR1 CELSR3 CELSR2 DSG4 PCDH9	1.47e-04	116	245	8	IPR015919
Domain	Ubiquitin-rel_dom	PLEKHG5 AXIN2 PIK3CD AFDN USP47 FRMD6 UHRF1 FRMPD3 GABPA FRMD3	1.64e-04	184	245	10	IPR029071
Domain	Cadherin	CDH23 PCDHGB7 PCDHGB6 CELSR1 CELSR3 CELSR2 DSG4 PCDH9	1.65e-04	118	245	8	IPR002126
Domain	PH_dom-like	SPTBN2 RGPD1 OBSCN PLEKHG5 PLEKHH3 OSBPL7 RGPD2 ARHGEF5 ARHGEF12 DOK4 FRMD6 OSBPL3 ARHGEF1 DNM3 FRMPD3 FRMD3	1.69e-04	426	245	16	IPR011993
Domain	UCR_hinge	UQCRH UQCRHL	1.71e-04	2	245	2	PF02320
Domain	Ubol_cytC_Rdtase_hinge_dom	UQCRH UQCRHL	1.71e-04	2	245	2	IPR023184
Domain	-	UQCRH UQCRHL	1.71e-04	2	245	2	1.10.287.20
Domain	Cyt_b-c1_6	UQCRH UQCRHL	1.71e-04	2	245	2	IPR003422
Domain	TPR_1	TTC21A RGPD1 IFIT5 TTC4 TOMM70 ST13P4 LONRF2	1.82e-04	90	245	7	IPR001440
Domain	TPR_1	TTC21A RGPD1 IFIT5 TTC4 TOMM70 ST13P4 LONRF2	1.82e-04	90	245	7	PF00515
Domain	-	SPTBN2 RGPD1 OBSCN PLEKHG5 PLEKHH3 OSBPL7 RGPD2 ARHGEF5 ARHGEF12 DOK4 FRMD6 OSBPL3 ARHGEF1 DNM3 FRMD3	2.15e-04	391	245	15	2.30.29.30
Domain	TPR	TTC21A RGPD1 IFIT5 TTC4 TOMM70 RGPD2 ST13P4 LONRF2	3.05e-04	129	245	8	SM00028
Domain	BTB	BTBD6 BTBD1 RHOBTB1 KLHL18 ANKFY1 ZBTB47 BTBD2 KLHL25	3.38e-04	131	245	8	PF00651
Domain	GAIN_dom_N	CELSR1 CELSR3 CELSR2	3.40e-04	11	245	3	IPR032471
Domain	GAIN	CELSR1 CELSR3 CELSR2	3.40e-04	11	245	3	PF16489
Domain	-	TTC21A RGPD1 IFIT5 TTC4 TRRAP SMYD4 TOMM70 HELZ RGPD2 LONRF2	4.21e-04	207	245	10	1.25.40.10
Domain	RGS-like_dom	ARHGEF12 ARHGEF1	5.10e-04	3	245	2	IPR015212
Domain	RGS-like	ARHGEF12 ARHGEF1	5.10e-04	3	245	2	PF09128
Domain	GABAAb_rcpt	GABRB1 GABRB3	5.10e-04	3	245	2	IPR002289
Domain	BTB	BTBD6 BTBD1 RHOBTB1 KCNC1 KLHL18 ANKFY1 ZBTB47 BTBD2 KLHL25	6.35e-04	180	245	9	SM00225
Domain	BTB/POZ_dom	BTBD6 BTBD1 RHOBTB1 KCNC1 KLHL18 ANKFY1 ZBTB47 BTBD2 KLHL25	7.72e-04	185	245	9	IPR000210
Domain	TPR-contain_dom	TTC21A RGPD1 IFIT5 TTC4 TOMM70 RGPD2 ST13P4 LONRF2	8.31e-04	150	245	8	IPR013026
Domain	SKP1/BTB/POZ	BTBD6 BTBD1 RHOBTB1 KCNC1 KLHL18 ANKFY1 ZBTB47 BTBD2 KLHL25	8.98e-04	189	245	9	IPR011333
Domain	Laminin_G	GAS6 COL22A1 CELSR1 CELSR3 CELSR2	9.70e-04	58	245	5	IPR001791
Domain	BACK	BTBD6 BTBD1 KLHL18 BTBD2 KLHL25	1.13e-03	60	245	5	SM00875
Domain	PH	SPTBN2 OBSCN PLEKHG5 PLEKHH3 OSBPL7 ARHGEF5 ARHGEF12 DOK4 OSBPL3 ARHGEF1 DNM3	1.16e-03	278	245	11	SM00233
Domain	PH_DOMAIN	SPTBN2 OBSCN PLEKHG5 PLEKHH3 OSBPL7 ARHGEF5 ARHGEF12 DOK4 OSBPL3 ARHGEF1 DNM3	1.19e-03	279	245	11	PS50003
Domain	BACK	BTBD6 BTBD1 KLHL18 BTBD2 KLHL25	1.22e-03	61	245	5	IPR011705
Domain	BACK	BTBD6 BTBD1 KLHL18 BTBD2 KLHL25	1.22e-03	61	245	5	PF07707
Domain	PH_domain	SPTBN2 OBSCN PLEKHG5 PLEKHH3 OSBPL7 ARHGEF5 ARHGEF12 DOK4 OSBPL3 ARHGEF1 DNM3	1.23e-03	280	245	11	IPR001849
Domain	BTB	BTBD6 BTBD1 RHOBTB1 KLHL18 ANKFY1 ZBTB47 BTBD2 KLHL25	1.26e-03	160	245	8	PS50097
Pathway	REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS	RGPD1 SMC5 NUP205 HERC2 NUP160 PML RGPD2 PIAS2 NUP93	1.31e-06	84	182	9	MM14929
Pathway	REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS	RGPD1 NUP205 NUP160 PML RGPD2 PIAS2 NUP93	2.17e-06	47	182	7	MM14939
Pathway	REACTOME_RHOD_GTPASE_CYCLE	ADD3 PIK3R1 HINT2 GOLGA2 PLXNA1 PLXNB1 ANKFY1	1.78e-05	64	182	7	MM15601
Pathway	REACTOME_RHOD_GTPASE_CYCLE	ADD3 PIK3R1 HINT2 PLXNA1 PLXNB1 ANKFY1	5.92e-05	53	182	6	M41811
Pathway	REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS	SMC5 NUP205 HERC2 NUP160 PML PIAS2 NUP93	5.98e-05	77	182	7	M27226
Pathway	REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS	NUP205 NUP160 PML PIAS2 NUP93	1.37e-04	39	182	5	M27238
Pathway	REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY	RGPD1 NUP205 NUP160 RGPD2 NUP93	1.55e-04	40	182	5	MM14945
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS	RGPD1 NUP205 NUP160 RGPD2 NUP93	1.75e-04	41	182	5	MM15200
Pathway	REACTOME_RHO_GTPASE_CYCLE	OBSCN PLEKHG5 RHOU ADD3 DOCK5 RHOBTB1 PIK3R1 HINT2 GOLGA2 PLXNA1 PLXNB1 ANKFY1 ARHGEF5 ARHGEF12 ARHGEF1 ARHGAP18	1.84e-04	439	182	16	MM15595
Pathway	REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS	RGPD1 NUP205 NUP160 RGPD2 PIAS2 NUP93	1.87e-04	65	182	6	MM15147
Pathway	REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS	RGPD1 NUP205 NUP160 RGPD2 NUP93	1.96e-04	42	182	5	MM15039
Pathway	REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA	RGPD1 NUP205 NUP160 RGPD2 NUP93	2.20e-04	43	182	5	MM14609
Pathway	REACTOME_RHO_GTPASE_CYCLE	OBSCN PLEKHG5 RHOU ADD3 DOCK5 RHOBTB1 PIK3R1 HINT2 CDC42EP5 PLXNA1 PLXNB1 ANKFY1 ARHGEF5 ARHGEF12 ARHGEF1 ARHGAP18	2.43e-04	450	182	16	M27078
Pathway	REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3	RGPD1 OBSCN NUF2 PLEKHG5 RHOU ADD3 DOCK5 RHOBTB1 PIK3R1 HINT2 NUP160 GOLGA2 PLXNA1 PLXNB1 RGPD2 ANKFY1 ARHGEF5 ARHGEF12 ARHGEF1 ARHGAP18	2.76e-04	649	182	20	MM15690
Pathway	REACTOME_SUMOYLATION	RGPD1 SMC5 NUP205 HERC2 NUP160 PML RGPD2 PIAS2 NUP93	3.48e-04	169	182	9	MM14919
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	SART3 ATRX PFAS ZZEF1 DOCK5 SMYD4 TOMM70 CARD6 HELZ AFDN GOLGA2 PLXNB1 SLC27A4 RBL1 ARHGEF5 RICTOR SIK3 PAPSS2 TBC1D17 RFWD3 ARNT OSBPL3 ARHGEF1 AP4B1 FIGNL1 ZC3HAV1 RAVER1	3.37e-13	650	251	27	38777146
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PALD1 NDOR1 OBSCN PFAS ZZEF1 TRRAP PLEKHG5 AHDC1 PLEKHH3 MDN1 PER2 PIK3CD HERC2 BRAT1 SMURF2 PLXNA1 RTTN TRMT1 GRIN2D MED13L TBC1D17 CELSR1 SCAP KLHL25 KANSL1 CELSR3 CELSR2 DOK4 HELZ2 OGDHL ZFYVE26 IL17RD ESPL1	6.05e-12	1105	251	33	35748872
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	ERCC1 ATRX ERC1 SPTBN2 IFIT5 BTBD1 ADD3 STXBP1 ADAMTS9 NFE2L2 PIK3R1 GLUL AFDN ATXN10 SMPD3 HERC2 SMURF2 USP47 BRWD1 ZBTB47 UBA3 BTBD2 MED13L PIAS2 SCYL2 HEATR6 CELSR3 PDE4DIP DNM3 LRP2 EXOC1 ATP2A2	1.24e-09	1285	251	32	35914814
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	SART3 ATRX ERC1 PFAS NUF2 TTC4 TRRAP NUP205 CDAN1 PIK3R1 AFDN ATXN10 HERC2 MED7 NUP160 SLC27A4 VIL1 KRT78 KRT82 UBA3 IPO4 PAPSS2 AZIN1 FRMD6 OSBPL3 NUP93 LTF AP4B1 ATP2A2	6.49e-08	1284	251	29	17353931
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	PRAMEF5 CAND2 ATRX OBSCN BCOR PRDM2 WWC2 PIK3CD FMN1 PIK3R1 TSTD2 PLXNB1 PRAMEF6 PML BRWD1 RICTOR CUBN SCAP OSBPL3 ARHGEF1 TLR4 LRP2 OGDHL ACCSL IL17RD ESPL1	1.03e-07	1084	251	26	11544199
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	SART3 PALD1 CAND2 IRF2BP1 ATRX ERC1 TTC21A CDH23 STYXL2 BCKDHB NUF2 NUP205 DOCK5 PIK3R1 HELZ AFDN ATXN10 VPS51 NUP160 RBL1 IPO4 AAR2 SCYL2 OSBPL3 EXOC1 VPS53 PCDH9 ZC3HAV1 RAVER1	1.18e-07	1321	251	29	27173435
Pubmed	Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy.	ZZEF1 TRRAP ALMS1 HELZ NUP160 PLXNA1 KRT82 RTTN ARHGEF12 CELSR3 ARHGEF1	1.32e-07	187	251	11	26460568
Pubmed	Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.	SART3 ERC1 SPTBN2 PFAS PLEKHG5 OSBPL7 PML BRWD1 ABCC1 TPCN2 TRMT1 RAD9B IPO4 KHDC4 TBC1D17 USP6 TRMT44 MZF1 ARHGEF1 CD44 UHRF1 MSLN ZC3HAV1	3.13e-07	925	251	23	28986522
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	SART3 SPTBN2 PFAS TRRAP NUP205 MDN1 HELZ AFDN HERC2 NUP160 USP47 WDR36 NVL IPO4 HELZ2 NUP93 LTF ATP2A2 ZC3HAV1	3.42e-07	653	251	19	22586326
Pubmed	The flamingo-related mouse Celsr family (Celsr1-3) genes exhibit distinct patterns of expression during embryonic development.	CELSR1 CELSR3 CELSR2	3.71e-07	3	251	3	11677057
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	IRF2BP1 ERC1 PFAS COL22A1 TRRAP NUP205 DOCK5 TOMM70 RHOBTB1 BRCA2 EDARADD NUP160 GOLGA2 ABCC1 RBL1 SCAP CD44 NUP93 LTF PCDH9	7.10e-07	754	251	20	35906200
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SPTBN2 PFAS SMYD4 RHOBTB1 ALMS1 ADAMTS9 KLHL18 NUP160 BAZ2B RICTOR MON1B KHDC4 RAB3GAP1 SCAP OSBPL3 HELZ2	7.22e-07	493	251	16	15368895
Pubmed	A dual role for planar cell polarity genes in ciliated cells.	FZD3 CELSR1 CELSR3 CELSR2	8.40e-07	11	251	4	25024228
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	SPTBN2 PFAS MDN1 ALMS1 PER2 HERC2 ARHGEF12 ZFYVE26	9.33e-07	104	251	8	9205841
Pubmed	Atypical cadherins Celsr1-3 differentially regulate migration of facial branchiomotor neurons in mice.	FZD3 CELSR1 CELSR3 CELSR2	1.25e-06	12	251	4	20631168
Pubmed	Abolishment of proximal tubule albumin endocytosis does not affect plasma albumin during nephrotic syndrome in mice.	NDOR1 CUBN LRP2	1.48e-06	4	251	3	29032953
Pubmed	The adhesion GPCRs CELSR1-3 and LPHN3 engage G proteins via distinct activation mechanisms.	CELSR1 CELSR3 CELSR2	1.48e-06	4	251	3	37224017
Pubmed	Developmental expression profiles of Celsr (Flamingo) genes in the mouse.	CELSR1 CELSR3 CELSR2	1.48e-06	4	251	3	11850187
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	ERC1 SPTBN2 RGPD1 BCOR HCN2 MDN1 GLUL AFDN HERC2 GOLGA2 RGPD2 ANKFY1 ARHGEF12 GRIN2D SIK3 IPO4 CELSR2 OSBPL3 SPHKAP PDE4DIP DNM3 FRMPD3	2.29e-06	963	251	22	28671696
Pubmed	A non-autonomous function of the core PCP protein VANGL2 directs peripheral axon turning in the developing cochlea.	FZD3 CELSR1 CELSR3 CD44	2.50e-06	14	251	4	29784671
Pubmed	HENA, heterogeneous network-based data set for Alzheimer's disease.	NUF2 ALMS1 HERC2 NUP160 CASS4 KANSL1 PDE4DIP EXOC1	2.76e-06	120	251	8	31413325
Pubmed	A ubiquitin-based effector-to-inhibitor switch coordinates early brain, craniofacial, and skin development.	BTBD6 CAND2 BTBD1 RHOBTB1 KLHL18 BTBD2 KLHL25	3.35e-06	87	251	7	37495603
Pubmed	Lack of cadherins Celsr2 and Celsr3 impairs ependymal ciliogenesis, leading to fatal hydrocephalus.	FZD3 CELSR1 CELSR3 CELSR2	3.40e-06	15	251	4	20473291
Pubmed	Planar cell polarity pathway regulates nephrin endocytosis in developing podocytes.	NPHS1 FZD3 CELSR2	3.67e-06	5	251	3	23824190
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	SART3 ERCC1 ATRX TRRAP NUP205 HERC2 NUP160 PML WDR36 NVL RICTOR NUP93 ESPL1 ZC3HAV1	4.52e-06	440	251	14	34244565
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	CAND2 ERC1 BTBD1 NUP205 TOMM70 ATXN10 UQCRH VPS51 BRAT1 SLC27A4 ABCC1 IPO4 AAR2 RAB3GAP1 SCAP ARHGEF1 NUP93 ESPL1 ATP2A2 VPS53 RAVER1	5.70e-06	942	251	21	31073040
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	SART3 ATRX ARMC3 ERC1 SPTBN2 RGPD1 ANKRD30B IFIT5 NUP205 MDN1 STXBP1 ATP11C UQCRH SMURF2 UQCRHL SLC27A4 VIL1 RGPD2 PCDHGB7 PCDHGB6 ATP6V1G1 AAR2 DOK4 OGDHL ATP2A2 PCK1 GABPA	6.59e-06	1442	251	27	35575683
Pubmed	Dual targeting of salt inducible kinases and CSF1R uncouples bone formation and bone resorption.	NDOR1 SIK3 CSF1R	7.31e-06	6	251	3	34160349
Pubmed	Discovery and Characterization of ZUFSP/ZUP1, a Distinct Deubiquitinase Class Important for Genome Stability.	USP35 VPS51 USP47 RICTOR RFWD3 USP6 HELZ2 VPS53	1.24e-05	147	251	8	29576527
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	PALD1 NUF2 ZZEF1 TTC4 TOMM70 MDN1 ALMS1 PIK3R1 HINT2 ATXN10 HERC2 NUP160 USP47 WDR36 FASTKD1 TRMT1 TBC1D17 SCYL2 RAB3GAP1 OSBPL3 LRP2 OGDHL ESPL1 ATP2A2 FIGNL1 ZC3HAV1 RAVER1	1.27e-05	1496	251	27	32877691
Pubmed	Early embryonic expression patterns of the mouse Flamingo and Prickle orthologues.	CELSR1 CELSR3 CELSR2	1.27e-05	7	251	3	17937400
Pubmed	Mouse screen reveals multiple new genes underlying mouse and human hearing loss.	PRAMEF5 CAND2 CDH23 TRRAP RHOU SMYD4 MDN1 GBP5 COG6 YDJC ATXN10 VPS51 KLHL18 PRAMEF6 ARMC7 SIK3 PIAS2 LRRC8D ZFYVE28 TRIM45 OSBPL3 ARHGEF1 ARHGAP18 VPS53	1.33e-05	1242	251	24	30973865
Pubmed	Loss of Zeb2 in mesenchyme-derived nephrons causes primary glomerulocystic disease.	NPHS1 VIL1 CUBN LRP2	1.44e-05	21	251	4	27591083
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	SART3 PALD1 CAND2 IRF2BP1 SPTBN2 NUP205 TOMM70 MDN1 COG6 UQCRH SLC27A4 PML ABCC1 WDR36 ING5 IPO4 RAB3GAP1 CD44 EXOC1 NUP93 LTF ATP2A2 VPS53 FIGNL1 ZC3HAV1 RAVER1	1.84e-05	1440	251	26	30833792
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	IRF2BP1 RGPD1 BCOR MDN1 STXBP1 UQCRH USP47 ANKFY1 SIK3 PIAS2 USP6 RAB3GAP1 DSG4 IL17RD DNAH11 RAVER1	1.87e-05	638	251	16	31182584
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	PCDHGB7 PCDHGB6 CELSR1 CELSR3 CELSR2 PCDH9	2.56e-05	80	251	6	10716726
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	ATRX BCOR TRRAP AHDC1 PRDM2 DOCK5 MDN1 NFE2L2 UQCRH SLC27A4 ABCC1 WDR36 BAZ2B ING5 RFWD3 INTS10 ARNT KANSL1 OSBPL3 UHRF1 NUP93 ATP2A2 ZC3HAV1 RAVER1	2.57e-05	1294	251	24	30804502
Pubmed	Genetic Steroid-Resistant Nephrotic Syndrome Overview	NUP160 NPHS1 NUP93	3.02e-05	9	251	3	34436835
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	GABRB1 GABRB3 SART3 ERC1 RGPD1 ADD3 STXBP1 GLUL HELZ AFDN VPS51 RGPD2 ATP6V1G1 RICTOR RAB3GAP1 CELSR2 SPHKAP IGHMBP2 PDE4DIP EXOC1 ATP2A2 ELP4	3.10e-05	1139	251	22	36417873
Pubmed	Identification of host proteins required for HIV infection through a functional genomic screen.	TOMM70 MDN1 MED7 NUP160 TRIM58 ARHGEF12 LRRC8D USP6 IGHMBP2 VPS53	3.18e-05	272	251	10	18187620
Pubmed	A protein network map of head and neck cancer reveals PIK3CA mutant drug sensitivity.	BTBD1 NFE2L2 PIK3R1 ARHGEF5 ARHGEF12 BTBD2	3.38e-05	84	251	6	34591642
Pubmed	Deficiency of Wdr60 and Wdr34 cause distinct neural tube malformation phenotypes in early embryos.	AXIN2 CELSR1 CELSR3 CELSR2	3.49e-05	26	251	4	37228654
Pubmed	Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.	ERC1 TOMM70 MDN1 HERC2 BRAT1 GOLGA2 SLC27A4 ABCC1 WDR36 FASTKD1 NVL TRMT1 SIK3 AAR2 HEATR6 IGHMBP2 PDE4DIP	3.93e-05	754	251	17	33060197
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	ERC1 SMC5 ALMS1 ANKFY1 SIK3 MED13L SCAP HELZ2 DNM3	4.12e-05	225	251	9	12168954
Pubmed	Celsr3 is required in motor neurons to steer their axons in the hindlimb.	FZD3 CELSR3 CELSR2	4.29e-05	10	251	3	25108913
Pubmed	Genome-wide shRNA screening identifies host factors involved in early endocytic events for HIV-1-induced CD4 down-regulation.	ATP6V1B1 STXBP1 GOLGA2 SCYL2 DNM3	4.46e-05	54	251	5	25496667
Pubmed	Defining the membrane proteome of NK cells.	NUF2 ITGAX NUP205 TOMM70 MDN1 GBP5 PIK3R1 HELZ ATXN10 HERC2 BRAT1 SLC27A4 ABCC1 NVL IPO4 LRRC8D OSBPL3 IGHMBP2 HELZ2 EXOC1 NUP93 MCTP2	4.50e-05	1168	251	22	19946888
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	PALD1 ERC1 SMC5 TOMM70 PER2 ANKFY1 ARHGEF12 MED13L KANSL1 SPHKAP PDE4DIP DNM3	4.57e-05	407	251	12	12693553
Pubmed	The cell proliferation antigen Ki-67 organises heterochromatin.	IRF2BP1 TRRAP STXBP1 ATXN10 WDR36 NVL HEATR6 ARHGEF1 DNM3 UHRF1 ATP2A2 VPS53	4.91e-05	410	251	12	26949251
Pubmed	VCP phosphorylation-dependent interaction partners prevent apoptosis in Helicobacter pylori-infected gastric epithelial cells.	TTC4 NUP205 MDN1 ATXN10 BRAT1 VIL1 RAB3GAP1 DNM3 ESPL1 VPS53	5.14e-05	288	251	10	23383273
Pubmed	Caffeine May Abrogate LPS-Induced Oxidative Stress and Neuroinflammation by Regulating Nrf2/TLR4 in Adult Mouse Brains.	NFE2L2 TLR4	5.19e-05	2	251	2	31717470
Pubmed	Knockout of the Complex III subunit Uqcrh causes bioenergetic impairment and cardiac contractile dysfunction.	UQCRH UQCRHL	5.19e-05	2	251	2	36565314
Pubmed	Epileptic encephalopathy de novo GABRB mutations impair γ-aminobutyric acid type A receptor function.	GABRB1 GABRB3	5.19e-05	2	251	2	26950270
Pubmed	Homo- and hetero-oligomerization of PDZ-RhoGEF, LARG and p115RhoGEF by their C-terminal region regulates their in vivo Rho GEF activity and transforming potential.	ARHGEF12 ARHGEF1	5.19e-05	2	251	2	14712228
Pubmed	Discovery of rare coding variants in OGDHL and BRCA2 in relation to breast cancer risk in Chinese women.	BRCA2 OGDHL	5.19e-05	2	251	2	31837001
Pubmed	Wogonin reverses multi-drug resistance of human myelogenous leukemia K562/A02 cells via downregulation of MRP1 expression by inhibiting Nrf2/ARE signaling pathway.	NFE2L2 ABCC1	5.19e-05	2	251	2	25264278
Pubmed	Expression and immunolocalisation of the endocytic receptors megalin and cubilin in the human yolk sac and placenta across gestation.	CUBN LRP2	5.19e-05	2	251	2	23978537
Pubmed	Dynamics of the phosphoinositide 3-kinase p110δ interaction with p85α and membranes reveals aspects of regulation distinct from p110α.	PIK3CD PIK3R1	5.19e-05	2	251	2	21827948
Pubmed	Nrf2 pathway regulates multidrug-resistance-associated protein 1 in small cell lung cancer.	NFE2L2 ABCC1	5.19e-05	2	251	2	23667609
Pubmed	Chromosomal localization of Celsr2 and Celsr3 in the mouse; Celsr3 is a candidate for the tippy (tip) lethal mutant on chromosome 9.	CELSR3 CELSR2	5.19e-05	2	251	2	10790539
Pubmed	Genetic defects in PI3Kδ affect B-cell differentiation and maturation leading to hypogammaglobulineamia and recurrent infections.	PIK3CD PIK3R1	5.19e-05	2	251	2	28104464
Pubmed	Acute endotoxemia in mice induces downregulation of megalin and cubilin in the kidney.	CUBN LRP2	5.19e-05	2	251	2	22437417
Pubmed	Plexin-A1 and plexin-B1 specifically interact at their cytoplasmic domains.	PLXNA1 PLXNB1	5.19e-05	2	251	2	12559962
Pubmed	Phosphatidylinositol 3-kinase is required for the transcriptional activation of cyclin D2 in BCR activated primary mouse B lymphocytes.	PIK3CD PIK3R1	5.19e-05	2	251	2	16114097
Pubmed	Celsr3 is required for Purkinje cell maturation and regulates cerebellar postsynaptic plasticity.	FZD3 CELSR3	5.19e-05	2	251	2	34308297
Pubmed	Expression and role of cubilin in the internalization of nutrients during the peri-implantation development of the rodent embryo.	CUBN LRP2	5.19e-05	2	251	2	15616221
Pubmed	Hyaluronan fragments/CD44 mediate oxidative stress-induced MUC5B up-regulation in airway epithelium.	MUC5B CD44	5.19e-05	2	251	2	18757307
Pubmed	Celsr3 and Fzd3 in axon guidance.	FZD3 CELSR3	5.19e-05	2	251	2	25813877
Pubmed	Silencing Nrf2 attenuates chronic suppurative otitis media by inhibiting pro-inflammatory cytokine secretion through up-regulating TLR4.	NFE2L2 TLR4	5.19e-05	2	251	2	32579053
Pubmed	E3 ligase RFWD3 is a novel modulator of stalled fork stability in BRCA2-deficient cells.	BRCA2 RFWD3	5.19e-05	2	251	2	32391871
Pubmed	Multiple modes for conferring surface expression of homomeric beta1 GABAA receptors.	GABRB1 GABRB3	5.19e-05	2	251	2	18650446
Pubmed	Adipose-derived mesenchymal stem cells promote the survival of fat grafts via crosstalk between the Nrf2 and TLR4 pathways.	NFE2L2 TLR4	5.19e-05	2	251	2	27607584
Pubmed	Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency.	PIK3CD PIK3R1	5.19e-05	2	251	2	24165795
Pubmed	Identification and characterization of BTBD1, a novel BTB domain containing gene on human chromosome 15q24.	BTBD1 BTBD2	5.19e-05	2	251	2	11179693
Pubmed	Plexin signaling hampers integrin-based adhesion, leading to Rho-kinase independent cell rounding, and inhibiting lamellipodia extension and cell motility.	PLXNA1 PLXNB1	5.19e-05	2	251	2	14734633
Pubmed	Characterization of an epithelial approximately 460-kDa protein that facilitates endocytosis of intrinsic factor-vitamin B12 and binds receptor-associated protein.	CUBN LRP2	5.19e-05	2	251	2	9334227
Pubmed	PI3Kδ inhibitors in cancer: rationale and serendipity merge in the clinic.	PIK3CD PIK3R1	5.19e-05	2	251	2	22586681
Pubmed	Silencing megalin and cubilin genes inhibits myeloma light chain endocytosis and ameliorates toxicity in human renal proximal tubule epithelial cells.	CUBN LRP2	5.19e-05	2	251	2	18448595
Pubmed	The epigenetic regulator UHRF1 promotes ubiquitination-mediated degradation of the tumor-suppressor protein promyelocytic leukemia protein.	PML UHRF1	5.19e-05	2	251	2	22945642
Pubmed	Giant obscurins regulate the PI3K cascade in breast epithelial cells via direct binding to the PI3K/p85 regulatory subunit.	OBSCN PIK3R1	5.19e-05	2	251	2	27323778
Pubmed	The Lipid Handling Capacity of Subcutaneous Fat Is Programmed by mTORC2 during Development.	NDOR1 RICTOR	5.19e-05	2	251	2	33027655
Pubmed	Hyaluronate-CD44 interactions can induce murine B-cell activation.	TLR4 CD44	5.19e-05	2	251	2	9108410
Pubmed	Nrf2 Regulates the Sensitivity of Mouse Keratinocytes to Nitrogen Mustard via Multidrug Resistance-Associated Protein 1 (Mrp1).	NFE2L2 ABCC1	5.19e-05	2	251	2	26454883
Pubmed	Deregulation of the planar cell polarity genes CELSR3 and FZD3 in Hirschsprung disease.	FZD3 CELSR3	5.19e-05	2	251	2	27619161
Pubmed	LOSS of Mrp1 alters detoxification enzyme expression in a tissue- and hormonal-status-specific manner.	NFE2L2 ABCC1	5.19e-05	2	251	2	22522787
Pubmed	Germline-activating mutations in PIK3CD compromise B cell development and function.	PIK3CD PIK3R1	5.19e-05	2	251	2	30018075
Pubmed	Polymorphisms in LRP2 and CUBN genes and their association with serum vitamin D levels and sleep apnea.	CUBN LRP2	5.19e-05	2	251	2	38008818
Pubmed	Megalin and cubilin in the human gallbladder epithelium.	CUBN LRP2	5.19e-05	2	251	2	18791690
Pubmed	Control of antioxidative response by the tumor suppressor protein PML through regulating Nrf2 activity.	NFE2L2 PML	5.19e-05	2	251	2	24943846
Pubmed	Megalin and cubilin: multifunctional endocytic receptors.	CUBN LRP2	5.19e-05	2	251	2	11994745
Pubmed	Megalin acts in concert with cubilin to mediate endocytosis of high density lipoproteins.	CUBN LRP2	5.19e-05	2	251	2	10766831
Pubmed	Flavonoids protect cerebrovascular endothelial cells through Nrf2 and PI3K from β-amyloid peptide-induced oxidative damage.	NFE2L2 PIK3R1	5.19e-05	2	251	2	22272764
Pubmed	A Novel Murine Anti-Lactoferrin Monoclonal Antibody Activates Human Polymorphonuclear Leukocytes through Membrane-Bound Lactoferrin and TLR4.	TLR4 LTF	5.19e-05	2	251	2	26649297
Pubmed	Cubilin and megalin expression and their interaction in the rat intestine: effect of thyroidectomy.	CUBN LRP2	5.19e-05	2	251	2	11595644
Pubmed	Drosophila ATP6AP2/VhaPRR functions both as a novel planar cell polarity core protein and a regulator of endosomal trafficking.	CELSR1 CELSR2	5.19e-05	2	251	2	23292348
Pubmed	PI3K contributed to modulation of spinal nociceptive information related to ephrinBs/EphBs.	PIK3R1 EPHB1	5.19e-05	2	251	2	22879882
Pubmed	Case Study: Mechanism for Increased Follicular Helper T Cell Development in Activated PI3K Delta Syndrome.	PIK3CD PIK3R1	5.19e-05	2	251	2	31031754
Pubmed	Dietary flavonoid (-)epicatechin stimulates phosphatidylinositol 3-kinase-dependent anti-oxidant response element activity and up-regulates glutathione in cortical astrocytes.	NFE2L2 PIK3R1	5.19e-05	2	251	2	18624917
Pubmed	In vitro methylation of nuclear respiratory factor-2 binding sites suppresses the promoter activity of the human TOMM70 gene.	TOMM70 GABPA	5.19e-05	2	251	2	18852034
Pubmed	GABAA receptors involved in sleep and anaesthesia: β1- versus β3-containing assemblies.	GABRB1 GABRB3	5.19e-05	2	251	2	21735059
Interaction	TOP3B interactions	PALD1 NDOR1 SPTBN2 OBSCN PFAS ZZEF1 TRRAP PLEKHG5 AHDC1 PLEKHH3 AXIN2 MDN1 PER2 FASTK PIK3CD HELZ HERC2 BRAT1 SMURF2 PLXNA1 WDR36 RTTN TRMT1 GRIN2D MED13L IPO4 TBC1D17 CELSR1 SCAP KLHL25 KANSL1 CELSR3 CELSR2 DOK4 HELZ2 OGDHL ZFYVE26 IL17RD ESPL1 ZC3HAV1	1.40e-06	1470	246	40	int:TOP3B
Interaction	ZBBX interactions	ZZEF1 FZD3 TBC1D17 CELSR1 CELSR2 DNM3	1.77e-06	31	246	6	int:ZBBX
Interaction	SCN2B interactions	CAND2 MDN1 COG6 ATP11C NUP160 FASTKD1 IPO4 DNM3 EXOC1	2.45e-06	95	246	9	int:SCN2B
Interaction	DUSP16 interactions	NUF2 ALMS1 BRCA2 COG6 HELZ VPS51 RICTOR SIK3 RAB3GAP1 SHROOM1 ARHGEF1 ESPL1 FIGNL1	7.42e-06	237	246	13	int:DUSP16
Interaction	TACSTD2 interactions	ATP6V1B1 CAND2 BTBD1 MDN1 NUP160 RTTN FASTKD1 HEATR6 CELSR2	2.99e-05	129	246	9	int:TACSTD2
Interaction	HRAS interactions	TTC21A ADD3 DOCK5 PIK3CD PIK3R1 TRPV2 AFDN VPS51 PLXNA1 PLXNB1 ABCC1 DUS4L RICTOR GRIN2D BTBD2 LRRC8D HEATR6 CELSR2 ARHGEF1 CD44 EXOC1 DCUN1D3 PCDH9	3.00e-05	725	246	23	int:HRAS
Interaction	CLOCK interactions	NUF2 TRRAP PER2 VPS51 KHDC4 ARNT EXOC1 VPS53	3.59e-05	102	246	8	int:CLOCK
Interaction	GUSBP5 interactions	NUF2 BCOR ALMS1 BRCA2 HELZ RICTOR RAB3GAP1	3.63e-05	75	246	7	int:GUSBP5
Cytoband	1p36.21	PRAMEF5 AADACL4 PRDM2 UQCRHL PRAMEF6 TMEM82	1.35e-06	63	252	6	1p36.21
Cytoband	20q13.31	FAM209B CASS4 PCK1	8.68e-05	16	252	3	20q13.31
Cytoband	3p21.31	KLHL18 PLXNB1 SCAP CELSR3 LTF	2.36e-04	100	252	5	3p21.31
GeneFamily	Adhesion G protein-coupled receptors, subfamily C\|CELSR cadherins	CELSR1 CELSR3 CELSR2	8.61e-07	3	173	3	913
GeneFamily	Adhesion G protein-coupled receptors, subfamily C\|CELSR cadherins	CELSR1 CELSR3 CELSR2	8.61e-07	3	173	3	1189
GeneFamily	Basic leucine zipper proteins\|BTB domain containing	BTBD6 BTBD1 RHOBTB1 KLHL18 ANKFY1 ZBTB47 BTBD2 KLHL25	4.47e-05	134	173	8	861
GeneFamily	UPF1 like RNA helicases	HELZ IGHMBP2 HELZ2	1.34e-04	11	173	3	1169
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	TTC21A RGPD1 IFIT5 TTC4 TOMM70 RGPD2	8.37e-04	115	173	6	769
GeneFamily	Ankyrin repeat domain containing\|FERM domain containing	PLEKHH3 FRMD6 FRMPD3 FRMD3	1.32e-03	50	173	4	1293
GeneFamily	Plexins	PLXNA1 PLXNB1	3.14e-03	9	173	2	683
GeneFamily	Zinc fingers FYVE-type\|Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors	ANKFY1 ZFYVE28 ZFYVE26	3.18e-03	31	173	3	81
GeneFamily	Nucleoporins	NUP205 NUP160 NUP93	3.48e-03	32	173	3	1051
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	OBSCN ARHGEF5 ARHGEF12 ARHGEF1	3.68e-03	66	173	4	722
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	SPTBN2 PLEKHG5 PLEKHH3 OSBPL7 DOK4 OSBPL3 DNM3	3.73e-03	206	173	7	682
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	GABRB3 ATRX CHRM5 AHDC1 PRDM2 MDN1 STXBP1 KCNC1 PIK3CD CACNA1I SMPD3 ST8SIA4 PLXNA1 BRWD1 TRIM58 ARHGEF12 RICTOR SIK3 MED13L PIAS2 CELSR3 DOK4 PDE4DIP DNM3 OGDHL FRMPD3 LONRF2 VPS53 PCDH9 FRMD3 EPHB1	9.32e-08	1106	251	31	M39071
ToppCell	LPS-IL1RA-Epithelial_airway\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARMC3 SPINT1 KRT78 MUC5B LRRC46 CELSR1 OSBPL3 MSLN DNAH11	3.46e-07	161	251	9	472c354f5ee148b37a5dfb795e83348ecb1643f1
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ATP6V1B1 SPTBN2 EDARADD TMEM117 PAPSS2 LRRC9 OGDHL ARHGAP18 LONRF2	4.05e-07	164	251	9	d847d509bb1791638032ade6755d8164586b5bd5
ToppCell	facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDH23 NUF2 RHOU RBL1 RFWD3 SCYL2 MZF1 LTF FIGNL1	5.75e-07	171	251	9	913bae728b5e653771a27c79a309eb023699f1d0
ToppCell	facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDH23 NUF2 RHOU RBL1 RFWD3 SCYL2 MZF1 LTF FIGNL1	5.75e-07	171	251	9	f28b2336057e353b96a6ff4581ec9fd0ca0789d9
ToppCell	normal_Lymph_Node-B_lymphocytes-GrB-secreting_B_cells\|normal_Lymph_Node / Location, Cell class and cell subclass	GAS6 LRRC69 SMPD3 PLD4 FZD3 MED13L USP6 CSF1R EPHB1	6.98e-07	175	251	9	29fbdfe1d3bfcb063be2bced0128a33176c5b78f
ToppCell	IIH-CD8-CD4_Treg\|IIH / Condition, Cell_class and T cell subcluster	IRF2BP1 NAGS BRCA2 FASTK FAM209B BRAT1 AAR2 OSBPL3 IGHMBP2	8.84e-07	180	251	9	d1a8b25115c80e5a5bd0b8244167a98250ab9778
ToppCell	COVID-19-kidney-Macrophages\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ITGAX GBP5 FMN1 GLUL ST8SIA4 CCDC170 CSF1R CD44 ARHGAP18	1.87e-06	197	251	9	3912301018d0863144dcfac8d1fa8adc081748d7
ToppCell	myeloid-pro-pDC\|World / Lineage and Cell class	PALD1 ERCC1 GAS6 BRCA2 SMPD3 KCNK17 PLD4 UHRF1 EPHB1	1.87e-06	197	251	9	8918ee006b16f6b86ed33ce1dd5c0f01f51f88f5
ToppCell	COVID-19-lung\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ITGAX FMN1 GLUL SMURF2 PAPSS2 CD44 ARHGAP18 MCTP2 ZC3HAV1	2.03e-06	199	251	9	155b03b859157013e9142e9248551369127d9204
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ATRX PLEKHG5 ADD3 STXBP1 AFDN BRWD1 BAZ2B ARHGEF12 ARHGAP18	2.11e-06	200	251	9	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARMC3 CCDC170 KRT78 MUC5B LRRC9 LRRC46 MSLN DNAH11	4.33e-06	164	251	8	e4d4c59aebe5cacd4ecdb907facd044dc82a831d
ToppCell	metastatic_Brain-Myeloid_cells-pDCs\|metastatic_Brain / Location, Cell class and cell subclass	GAS6 HCN2 SMPD3 KCNK17 PLD4 TRIM58 LONRF2 EPHB1	4.33e-06	164	251	8	06db4cc064f0765c481ce880207823872c27bfa9
ToppCell	droplet-Marrow-nan-21m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN ITGAX RHOU DOCK5 SLC27A4 PLD4 CSF1R IL17RD	5.89e-06	171	251	8	355a27ea88410a84210f7e4298c7c4f90cf2f8a9
ToppCell	normal_Pleural_Fluid-Myeloid_cells-CD1c+_DCs\|normal_Pleural_Fluid / Location, Cell class and cell subclass	RNF144B ITGAX DOCK5 SMPD3 KCNK17 PLD4 CASS4 CCNG2	6.15e-06	172	251	8	200b2e63313b110b8ca59ee5b72c02cc8ed907cd
ToppCell	metastatic_Brain-B_lymphocytes-GrB-secreting_B_cells\|B_lymphocytes / Location, Cell class and cell subclass	PALD1 CDH23 FMN1 SMPD3 KCNK17 PLD4 ZFYVE28 UHRF1	7.59e-06	177	251	8	43e1d0d3cf8f0c02e67d91f8dd1761df23d59e07
ToppCell	moderate-Myeloid-pDC\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	PALD1 GAS6 MDN1 SMPD3 KCNK17 PLD4 FZD3 PCDH9	8.58e-06	180	251	8	1d8df7df03a71f49d6683554d3c948ce90dda42e
ToppCell	droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NUF2 DOCK5 PRRG4 USP35 PLXNA1 HEATR6 ARHGAP18 FIGNL1	8.94e-06	181	251	8	3fe648db1cb8326066d8bde3ca1287c5c9af19bd
ToppCell	droplet-Fat-SCAT-30m-Epithelial\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BRCA2 YDJC PLXNB1 MUC5B TRIM45 CELSR2 OSBPL3 LTF	1.13e-05	187	251	8	5fada3c5a58c1890029ccbfff2608b33f8cd2df7
ToppCell	droplet-Fat-SCAT-30m-Epithelial-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BRCA2 YDJC PLXNB1 MUC5B TRIM45 CELSR2 OSBPL3 LTF	1.13e-05	187	251	8	766e808138fc2cd623c2e6d57fcb5c7378da0e03
ToppCell	droplet-Fat-SCAT-30m-Epithelial-epithelial_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BRCA2 YDJC PLXNB1 MUC5B TRIM45 CELSR2 OSBPL3 LTF	1.13e-05	187	251	8	f49d06600060deeb2fc1b1da5b93496535f20104
ToppCell	pdx-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	RGPD1 FMN1 CACNA1I ABCC1 RTTN CD44 IL17RD EPHB1	1.13e-05	187	251	8	7e376831a11ee72ed87abcdac631ca46ae29c250
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PALD1 ITGAX GBP5 PIK3CD FMN1 ST8SIA4 PLD4 CSF1R	1.18e-05	188	251	8	0d7296ad26e97ad91c6927a6cfe4e6e70a74c5a6
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ITGAX DOCK5 GLUL PLXNB1 CSF1R TLR4 LRP2 KIAA1755	1.22e-05	189	251	8	42ab4cc5fbf8580841f31889446fe4499df1a464
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PALD1 ITGAX GBP5 PIK3CD FMN1 ST8SIA4 PLD4 CSF1R	1.27e-05	190	251	8	7c402aa47f1bd7decacc366c1ed1a37e39b95c73
ToppCell	COVID-19_Mild-PLT_1\|World / Disease Group and Platelet Clusters	ARMC3 RHOBTB1 GLUL VIL1 ARMC7 ING5 ARHGAP18 FRMD3	1.37e-05	192	251	8	c86cb4b2df5102af904c362f3cbd24fe4462ba6c
ToppCell	VE-pDC-\|VE / Condition, Cell_class and T cell subcluster	RNF144B PALD1 GAS6 CDH23 SMPD3 KCNK17 PLD4 EPHB1	1.42e-05	193	251	8	583724de588fcde3aeda056138c522dc0225a387
ToppCell	VE-pDC\|VE / Condition, Cell_class and T cell subcluster	RNF144B PALD1 GAS6 CDH23 SMPD3 KCNK17 PLD4 EPHB1	1.42e-05	193	251	8	bb759dc9ef0ec41d655002f59021d62d62d44289
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HCN2 RHOU ADD3 DOCK5 AK5 SIK3 DNM3 LRP2	1.48e-05	194	251	8	cb0422e7607dbd77204428b7e2c70dfe14a6ca11
ToppCell	Adult-Immune-interstitial_macrophage_(C1Q_positive)-D231\|Adult / Lineage, Cell type, age group and donor	CDH23 ITGAX FMN1 GLUL CCDC170 CASS4 CSF1R ARHGAP18	1.48e-05	194	251	8	800d3d7a9e864d2d6a100a4e4af22f45d5790a8d
ToppCell	COVID-19-Myeloid-Monocyte-derived_macrophages\|COVID-19 / group, cell type (main and fine annotations)	RNF144B ITGAX FMN1 GLUL ST8SIA4 CSF1R TLR4 ARHGAP18	1.53e-05	195	251	8	c172c5599379c29123340621a36bfb1fc90c2115
ToppCell	COVID-19-lung-Macrophage_CD163hi_MERTKhi\|lung / Disease (COVID-19 only), tissue and cell type	RNF144B ITGAX GBP5 FMN1 GLUL ST8SIA4 CSF1R ARHGAP18	1.53e-05	195	251	8	148fff8c3c9ba45ec36e98dff1be57e3f8294506
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	RNF144B ITGAX PLEKHG5 FMN1 GLUL TRPV2 CSF1R ARHGAP18	1.53e-05	195	251	8	247803cf58c6d9c561a52aa34e581188ddad197e
ToppCell	distal-Hematologic-Myeloid_Dendritic_Type_2-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PALD1 BTBD1 GRAMD4 DOCK5 FMN1 ST8SIA4 PLD4 CSF1R	1.53e-05	195	251	8	7606b8b40e704bb5447ac57ccf8698794e9c7890
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ADD3 EDARADD USP47 RGPD2 WDR36 CD44 FRMPD3 ZC3HAV1	1.59e-05	196	251	8	ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de
ToppCell	droplet-Mammary_Gland-nan-3m-Epithelial-luminal_progenitor_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP6V1B1 SPINT1 GAS6 RHOU PRRG4 ARHGEF5 CELSR2 LTF	1.59e-05	196	251	8	22fcfb713f402ebbd43b2822f0fd919cdbfba6e4
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	GABRB1 ANKRD18B KCNC1 KCNK17 USP6 CELSR3 CELSR2 OGDHL	1.59e-05	196	251	8	4bdc304c0c9d8bebe1a6a8a27e44acd1e8113725
ToppCell	COVID-19-lung-Macrophage_CD163hi_MERTKhi\|COVID-19 / Disease (COVID-19 only), tissue and cell type	RNF144B ITGAX GBP5 FMN1 GLUL ST8SIA4 CSF1R ARHGAP18	1.59e-05	196	251	8	7026c1fc33425e5476063d17c79e4b79356a9e01
ToppCell	proximal-Epithelial-Neuroendocrine\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	GABRB1 HCN2 DIO2 VIL1 SPHKAP OGDHL ESPL1 PCK1	1.71e-05	198	251	8	5dea6078488d584513c0bdbf5bba54877310b54a
ToppCell	proximal-Epithelial-Neuroendocrine-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	GABRB1 HCN2 DIO2 VIL1 SPHKAP OGDHL ESPL1 PCK1	1.71e-05	198	251	8	00ccf3020667cf2130bc354b441b65c0b1b0e862
ToppCell	COVID-19-kidney-Macrophages\|kidney / Disease (COVID-19 only), tissue and cell type	ITGAX GBP5 FMN1 GLUL ST8SIA4 CCDC170 CSF1R CD44	1.71e-05	198	251	8	161324541fe5da5cbb58142ea94fefd39b7dfb04
ToppCell	proximal-3-Epithelial-Neuroendocrine\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	GABRB1 HCN2 DIO2 VIL1 SPHKAP OGDHL ESPL1 PCK1	1.71e-05	198	251	8	a6bc043faf68468d46bac441cf7447c236c7bae4
ToppCell	10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HCN2 RHOU FGF1 PLXNB1 CELSR2 DNM3 LRP2 PCDH9	1.78e-05	199	251	8	5d2e85e40b6b52b1809e680b952913d77215b3d0
ToppCell	10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HCN2 RHOU FGF1 PLXNB1 CELSR2 DNM3 LRP2 PCDH9	1.78e-05	199	251	8	6fb5f931e6217142de38c1fffc011e63bda4772b
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	WWC2 PLXNA1 PLXNB1 PAPSS2 CELSR1 DOK4 OSBPL3 ARHGEF1	1.78e-05	199	251	8	d43c605a4ff221cf78d91678c15d2ad20f831c7f
ToppCell	10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HCN2 RHOU FGF1 PLXNB1 CELSR2 DNM3 LRP2 PCDH9	1.78e-05	199	251	8	9dd4b17fb8c70ab9e126b23b72600463f3db832d
ToppCell	10x_5'_v1-Non-neoplastic-Glial-Neuronal\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HCN2 RHOU FGF1 PLXNB1 CELSR2 DNM3 LRP2 PCDH9	1.78e-05	199	251	8	1bb5797e8e0552bf9b44bf4c958d1aa6dbe6c756
ToppCell	Control_saline-Endothelial-Endothelial-Gen_Cap\|Control_saline / Treatment groups by lineage, cell group, cell type	PLEKHG5 ADD3 STXBP1 AFDN PML BAZ2B ARHGEF12 ARHGAP18	1.84e-05	200	251	8	3b97920e1e6e2f09ddba2a861baa9c00c2970f4c
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	WWC2 PLXNB1 PAPSS2 CELSR1 DOK4 OSBPL3 ARHGEF1 OGDHL	1.84e-05	200	251	8	8683445ad5b70748c4a1f12eb77d47623085147e
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HCN2 RHOU DOCK5 AK5 FGF1 DNM3 LRP2 PCDH9	1.84e-05	200	251	8	159377d904394d91e09913131e9a93e08189955a
ToppCell	control\|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	SPINT1 PLEKHH3 AFDN PRRG4 PLXNB1 ARHGEF12 CELSR1 ATP2A2	1.84e-05	200	251	8	97f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HCN2 RHOU DOCK5 AK5 FGF1 DNM3 LRP2 PCDH9	1.84e-05	200	251	8	3ce8a2db8c25e1169a0a544f644a63104749c5ee
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ATRX PLEKHG5 ADD3 STXBP1 AFDN BAZ2B ARHGEF12 ARHGAP18	1.84e-05	200	251	8	a2b9d1cd291d17abddc3ee2e242121412c864b8b
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HCN2 RHOU DOCK5 AK5 FGF1 DNM3 LRP2 PCDH9	1.84e-05	200	251	8	0bfd41c12887479ceb62c3db0a3c3ba5007eb62b
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HCN2 RHOU DOCK5 AK5 FGF1 DNM3 LRP2 PCDH9	1.84e-05	200	251	8	d30316836494f33ca46d4e415fd2ed179e9cb5ee
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK5 ADAMTS9 FGF1 NPHS1 TRIM58 FRMPD3 FRMD3	2.85e-05	155	251	7	5a872ca70ae8c30b57f45a6772d7bf565e0c2663
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK5 ADAMTS9 FGF1 NPHS1 TRIM58 FRMPD3 FRMD3	2.85e-05	155	251	7	e7f49e2fdaf184fa6b4e685518004e7deff1316d
ToppCell	PND14-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RNF144B ITGAX TRPV2 PLD4 CCDC170 UHRF1 FIGNL1	2.97e-05	156	251	7	8349604bd801e20d33770f7d8243598c3756302b
ToppCell	PBMC-Control-cDC_1\|Control / Compartment, Disease Groups and Clusters	IFIT5 PML ZBTB47 ZNF23 HELZ2 PNMA6A ZC3HAV1	2.97e-05	156	251	7	9b6c5bcac516a62bcc1f5be32ffa8c92735ef0bc
ToppCell	Control-Epithelial_airway\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARMC3 SPINT1 KRT78 LRRC46 CELSR1 OSBPL3 DNAH11	3.22e-05	158	251	7	35aee1c3b92169e73569331022833cb44ab7e7e8
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PLXNA1 ZFYVE28 TRMT44 UHRF1 KIAA1755 GASK1A DNAH11	3.36e-05	159	251	7	7ed659163f45e0c4df4782997c0786900c8186c8
ToppCell	URO-Other-RBC\|URO / Disease, Lineage and Cell Type	GAS6 BCKDHB SMPD3 KCNK17 PLD4 FZD3 IL17RD	3.49e-05	160	251	7	558f3b0719e2461a69e1b93b08e21675e8d07a5a
ToppCell	COVID_non-vent-Lymphocytic-Dendritic-pDC\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	PALD1 GAS6 SMPD3 KCNK17 PLD4 RNASE10 EPHB1	3.49e-05	160	251	7	61f4cb4eb4313d8318aadbb99595a6cb7fd919f7
ToppCell	URO-Other\|URO / Disease, Lineage and Cell Type	GAS6 BCKDHB SMPD3 KCNK17 PLD4 FZD3 IL17RD	3.49e-05	160	251	7	b0923e6bacfaba8ca40aa5706bf270eea0938b0a
ToppCell	COVID_non-vent-Lymphocytic-Dendritic\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	PALD1 GAS6 SMPD3 KCNK17 PLD4 RNASE10 EPHB1	3.49e-05	160	251	7	34b4f710cfcb6ec370b8b074f3cbfe272f392cec
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FMN1 CARD6 HERC2 BRWD1 ANKFY1 CUBN ARHGEF1	3.64e-05	161	251	7	5fba13f0aa5002f7eefe219e2c6a07e163f1a50d
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Myeloid-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GDF9 TMEM117 PLD4 TPCN2 ZBTB47 CSF1R ESPL1	3.78e-05	162	251	7	b502d6af6868425b5c919740e011330c0d3cf3b8
ToppCell	Bac-SEP-Myeloid-tDC\|Bac-SEP / Disease, Lineage and Cell Type	GAS6 AHDC1 RHOU NAGS PLD4 MSLN EPHB1	4.25e-05	165	251	7	8728f927502e56f2768b4224e9111939d3d7815a
ToppCell	LPS-IL1RA-Epithelial_airway-Club_cells\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SPINT1 KRT78 MUC5B CELSR1 OSBPL3 MSLN DNAH11	4.25e-05	165	251	7	1a114eacaab598f755a173a3fed842ba91f689dd
ToppCell	LPS-IL1RA-Epithelial_airway-Club_cells-Airway\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SPINT1 KRT78 MUC5B CELSR1 OSBPL3 MSLN DNAH11	4.25e-05	165	251	7	9cfd3c1d2c6d714fde83b90465f1f9741b0e50ce
ToppCell	Cerebellum-Macroglia-ASTROCYTE-Gja1-Gfap+_astrocytes_(Gfap)--\|Cerebellum / BrainAtlas - Mouse McCarroll V32	NUF2 ADAMTS9 DIO2 PAPSS2 CELSR1 TMEM82	4.36e-05	113	251	6	fed408864201218295bac0cc6647953fda8d688e
ToppCell	Cerebellum-Macroglia-ASTROCYTE-Gja1-Gfap+_astrocytes_(Gfap)-\|Cerebellum / BrainAtlas - Mouse McCarroll V32	NUF2 ADAMTS9 DIO2 PAPSS2 CELSR1 TMEM82	4.36e-05	113	251	6	c0b8d7a2e3722029e850051bdff77f31f34a8cca
ToppCell	Cerebellum-Macroglia-ASTROCYTE-Gja1-Gfap+_astrocytes_(Gfap)\|Cerebellum / BrainAtlas - Mouse McCarroll V32	NUF2 ADAMTS9 DIO2 PAPSS2 CELSR1 TMEM82	4.36e-05	113	251	6	7e24c0f6a80e10a2a41325d48a87628bd330a1e2
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SPTBN2 EDARADD TMEM117 PAPSS2 LRRC9 ARHGAP18 LONRF2	4.42e-05	166	251	7	6fe8db8d45177a78605681f22e04fa8d0594f2df
ToppCell	10x5'-Liver-Myeloid_Dendritic-pDC\|Liver / Manually curated celltypes from each tissue	GAS6 SMPD3 KCNK17 PLD4 USP6 PCDH9 EPHB1	4.42e-05	166	251	7	24dfa9f3e0842f9ab8350bf6a52ae0d10f2a0c44
ToppCell	5'-Adult-Appendix-Hematopoietic-Myeloid-cDC2\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RNF144B PALD1 HCN2 ITGAX PLD4 CSF1R IGHMBP2	4.59e-05	167	251	7	1bd0aa7a3c8649f342bb856cf861c4c5984ad889
ToppCell	facs-Marrow-KLS-3m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP6V1B1 TTC21A BCOR AXIN2 CDC42EP5 ZBTB47 SHROOM1	4.59e-05	167	251	7	2812353ff66e76f10bd327ceb0e6b009502a5258
ToppCell	facs-Marrow-KLS-3m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP6V1B1 TTC21A BCOR AXIN2 CDC42EP5 ZBTB47 SHROOM1	4.59e-05	167	251	7	d15168f46c1599d9fc68a05a7b822c4b439f2987
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell-mesothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SPTBN2 SMPD3 TMEM117 ZNF23 MCTP2 MSLN FRMD3	4.59e-05	167	251	7	1adb566f98af0109c8cc6e36033b89651e2c75e7
ToppCell	mild_COVID-19_(asymptomatic)-pDC\|World / disease group, cell group and cell class (v2)	PALD1 GAS6 AHDC1 KCNK17 PLD4 GASK1A EPHB1	4.59e-05	167	251	7	bf08f17965a4dd03f371b4ed0ab0d5e62ed61307
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SPTBN2 SMPD3 TMEM117 ZNF23 MCTP2 MSLN FRMD3	4.59e-05	167	251	7	743df5908c1ceb43b34b240d9f9649f30f4142fa
ToppCell	367C-Lymphocytic-ILC-ILC-1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	NDOR1 ITGAX PIK3R1 NPHS1 FASTKD1 LONRF2 DCUN1D3	4.77e-05	168	251	7	80233a13135fd159f5764336a1fe67fba237776b
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-mesothelial_cell\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	AXIN2 FGF1 NPHS1 AMHR2 SPHKAP LRP2 MSLN	4.95e-05	169	251	7	0cece9b2bb1f58e465c20ec8735a4fc3c1021f03
ToppCell	3'_v3-Lung-Myeloid_Mac-Intestinal_macrophages\|Lung / Manually curated celltypes from each tissue	PALD1 GAS6 RHOBTB1 FMN1 PCDHGB7 CSF1R PNMA6A	4.95e-05	169	251	7	241644823e6f949aaf4c671d4579721d7ef6b0e5
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	AXIN2 FGF1 NPHS1 AMHR2 SPHKAP LRP2 MSLN	4.95e-05	169	251	7	6937c46b119d4ce382fc8c2fa5925ede5ae89c81
ToppCell	Bronchial_Brush-Immune-B_cells\|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X	ARMC3 PLEKHH3 ADD3 NUP160 TRIM58 FZD3 AP4B1	5.14e-05	170	251	7	53e9372cb06a2dc5c8ecb3f9af42f3c23da96431
ToppCell	TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-8\|TCGA-Liver / Sample_Type by Project: Shred V9	TDRD15 SPTBN2 GAS6 GRAMD4 PAPSS2 OGDHL UPP2	5.33e-05	171	251	7	c4a919fe3d56ae6df2fcab6686abacc10befc053
ToppCell	368C-Myeloid-Dendritic-pDC\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	PFAS SMPD3 KCNK17 PLD4 DUS4L RICTOR EPHB1	5.33e-05	171	251	7	714a0b0d0c9886fef64170cf53eb64f0d8a47280
ToppCell	metastatic_Lymph_Node-Myeloid_cells-pDCs\|metastatic_Lymph_Node / Location, Cell class and cell subclass	PALD1 GAS6 SMPD3 KCNK17 PLD4 LONRF2 EPHB1	5.33e-05	171	251	7	1f8e66073088fc1969782e443bf00f8c1877ea91
ToppCell	droplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SPINT1 PFAS ITGAX ALMS1 LRRC46 UHRF1 PCK1	5.53e-05	172	251	7	b043d4f81dced7fb3326043f68474123be47cc5d
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_12\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	AADACL4 SPINT1 GAS6 PLD4 CSF1R UHRF1 MSLN	5.74e-05	173	251	7	9c7386bf0a899882c733f0b4921a96afde032a7d
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_12\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	AADACL4 SPINT1 GAS6 PLD4 CSF1R UHRF1 MSLN	5.74e-05	173	251	7	a55f310c533432e9e26e400026a5b47245152976
ToppCell	CTRL-Lymphoid-pDC\|Lymphoid / Disease state, Lineage and Cell class	PALD1 GAS6 PFAS BRCA2 DIO2 SMPD3 EPHB1	5.95e-05	174	251	7	ff4315e9fad198cc323fc987deb8652da137cf98
ToppCell	IPF-Myeloid-pDC\|World / Disease state, Lineage and Cell class	PALD1 GAS6 PFAS SMPD3 KCNK17 PLD4 EPHB1	6.17e-05	175	251	7	a06785a4ded01adfd29ca4c20f7759eccbe274cb
ToppCell	mild-Myeloid-pDC\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	PALD1 GAS6 SMPD3 KCNK17 PLD4 FZD3 C17orf113	6.39e-05	176	251	7	59a9c262c252b7d220a025837922d98e9d6b0a24
ToppCell	COVID-19-kidney-CD-IC-A\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SPTBN2 EDARADD TMEM117 ARMC7 OGDHL ARHGAP18 LONRF2	6.39e-05	176	251	7	45028197364c64e93e3ffe86aff773d47a477d49
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PALD1 PIK3CD SMPD3 KCNK17 PLD4 ZFYVE26 EPHB1	6.39e-05	176	251	7	8488997e0f02e874f53fae1690da63e0dd1d0780
ToppCell	PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LRRC39 NUF2 NUP160 KLHL25 TLR4 CD44 ZFYVE26	6.62e-05	177	251	7	1d5a071157c755f3a27a5c3143015da04ee0b0dc
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ERC1 SPTBN2 COL22A1 EDARADD TMEM117 LRRC9 ARHGAP18	6.62e-05	177	251	7	f35b04c3557ebbdeba37dec54c8f45880eafb422
ToppCell	LA-17._Lymphocyte\|World / Chamber and Cluster_Paper	TDRD15 GBP5 PIK3CD CD44 ARHGAP18 MCTP2 ZC3HAV1	6.86e-05	178	251	7	34ec499d03cc198cfefa19a724d4c81974052f65
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-astrocyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NDOR1 NUF2 TPCN2 LRRC9 KANSL1 EXOC1	7.00e-05	123	251	6	a45d6907c041ad3f3218cd46dccfc25d4bd961cb
Drug	radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; HL60; HT_HG-U133A	PFAS BCKDHB AHDC1 RHOBTB1 PIK3R1 PML ANKFY1 TRIM58 DUS4L PAPSS2 OSBPL3 ATP2A2	1.63e-06	194	249	12	6178_DN
Drug	Se-methylselenocysteine	ITGAX PER2 PIK3CD PIK3R1 ABCC1 PAPSS2 PCK1	9.45e-06	68	249	7	CID000114835
Drug	Metanephrine hydrochloride DL [881-95-8]; Down 200; 17.2uM; PC3; HT_HG-U133A	IRF2BP1 ZZEF1 CACNA1I VGLL1 PLXNB1 CASS4 BTBD2 ARNT CELSR2 PDE4DIP DNM3	9.69e-06	193	249	11	6734_DN
Drug	Dehydroisoandosterone 3-acetate [853-23-6]; Up 200; 12.2uM; PC3; HT_HG-U133A	NDOR1 PRDM2 PER2 AFDN KLHL18 PML ARHGEF12 SCYL2 ARNT PDE4DIP CD44	1.02e-05	194	249	11	6673_UP
Disease	NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE	NUP205 NUP160 NPHS1 ANKFY1 NUP93	3.96e-06	30	238	5	C1868672
Disease	total lipids in small VLDL	ANKRD31 TDRD15 GAS6 SIK3 INTS10 CELSR2	1.71e-05	67	238	6	EFO_0022148
Disease	Adenoid Cystic Carcinoma	ATRX GAS6 BCOR KANSL1 UHRF1 IL17RD ESPL1	1.72e-05	100	238	7	C0010606
Disease	Activated PI3K-delta syndrome	PIK3CD PIK3R1	6.48e-05	2	238	2	cv:CN295305
Disease	lung small cell carcinoma (is_implicated_in)	ATRX AXIN2 PIK3R1 RICTOR	7.26e-05	28	238	4	DOID:5409 (is_implicated_in)
Disease	ovarian neoplasm	BRCA2 PIK3R1 FGF1 LRRC46 KANSL1 TLR4 MSLN	1.12e-04	134	238	7	C0919267
Disease	phospholipids in VLDL measurement	TDRD15 GAS6 SIK3 INTS10 CELSR2	1.15e-04	59	238	5	EFO_0022301
Disease	total lipids in VLDL measurement	TDRD15 GAS6 SIK3 INTS10 CELSR2	1.25e-04	60	238	5	EFO_0022314
Disease	Malignant neoplasm of ovary	BRCA2 PIK3R1 FGF1 LRRC46 KANSL1 TLR4 MSLN	1.29e-04	137	238	7	C1140680
Disease	cholesterol in large VLDL measurement	TDRD15 GAS6 SIK3 INTS10 CELSR2	1.82e-04	65	238	5	EFO_0021902
Disease	ACTIVATED PI3K-DELTA SYNDROME	PIK3CD PIK3R1	1.93e-04	3	238	2	C3714976
Disease	breast ductal carcinoma (is_implicated_in)	RICTOR CD44	1.93e-04	3	238	2	DOID:3007 (is_implicated_in)
Disease	free cholesterol in large VLDL measurement	ANKRD31 TDRD15 SIK3 INTS10 CELSR2	2.26e-04	68	238	5	EFO_0022265
Disease	lung small cell carcinoma (is_marker_for)	ATRX RICTOR CSF1R	2.68e-04	16	238	3	DOID:5409 (is_marker_for)
Disease	response to acetylsalicylate	KLHL18 SCAP EPHB1	2.68e-04	16	238	3	GO_1903492
Disease	free cholesterol measurement	ANKRD31 TDRD15 IRF2BP1 GAS6 NUP160 CELSR2	3.18e-04	113	238	6	EFO_0008591
Disease	Vitiligo	NFE2L2 PIK3R1 CD44	3.24e-04	17	238	3	C0042900
Disease	omega-3 polyunsaturated fatty acid measurement	TDRD15 GAS6 BRWD1 KANSL1 CELSR2 IGHMBP2	4.01e-04	118	238	6	EFO_0010119
Disease	low density lipoprotein cholesterol measurement, phospholipid measurement	TDRD15 GAS6 BRCA2 BRWD1 CELSR2 DNAH11	4.39e-04	120	238	6	EFO_0004611, EFO_0004639
Disease	Malignant neoplasm of kidney	BCOR BRCA2 DNM3 FIGNL1	4.74e-04	45	238	4	C0740457
Disease	Acute Promyelocytic Leukemia	BCOR ITGAX PML CD44	5.16e-04	46	238	4	C0023487
Disease	very low density lipoprotein cholesterol measurement, phospholipid measurement	TDRD15 GAS6 PIK3R1 BRWD1 SIK3 INTS10 CELSR2 DNAH11	5.74e-04	229	238	8	EFO_0004639, EFO_0008317
Disease	cortical surface area measurement	PALD1 RGPD1 LRRC69 COL22A1 ADAMTS9 PIK3CD PIK3R1 YDJC USP35 ATXN10 AMHR2 FZD3 BAZ2B ARHGEF12 MED13L CELSR1 KANSL1 UHRF1 KIAA1755 IL17RD MCTP2 DNAH11 EPHB1	5.98e-04	1345	238	23	EFO_0010736
Disease	Malignant Neoplasms	ERCC1 PIK3R1 CSF1R LTF DCUN1D3 MSLN	6.18e-04	128	238	6	C0006826
Disease	esterified cholesterol measurement	ANKRD31 TDRD15 IRF2BP1 NUP160 SIK3 CELSR2	6.18e-04	128	238	6	EFO_0008589
Disease	lung adenocarcinoma (is_marker_for)	ATRX NUF2 PIK3R1 CSF1R CD44	6.35e-04	85	238	5	DOID:3910 (is_marker_for)
Disease	whole-brain volume	CUBN DNAH11	6.38e-04	5	238	2	EFO_0005089
Disease	developmental disorder of mental health (implicated_via_orthology)	GABRB1 GABRB3 PLXNB1 GRIN2D	6.58e-04	49	238	4	DOID:0060037 (implicated_via_orthology)
Disease	choline measurement	TDRD15 YDJC SIK3 KANSL1 CELSR2 NUP93	6.71e-04	130	238	6	EFO_0010116
Disease	Bronchiectasis	PIK3CD PIK3R1 DNAH11	7.12e-04	22	238	3	C0006267
Disease	total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement	ANKRD31 TDRD15 SIK3 CELSR2	7.66e-04	51	238	4	EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928
Disease	cholesterol to total lipids in small VLDL percentage	ANKRD31 TDRD15 SIK3 CELSR2	7.66e-04	51	238	4	EFO_0022242
Disease	Carcinoma of lung	ERCC1 BRCA2 RICTOR	8.14e-04	23	238	3	C0684249
Disease	total lipids in medium VLDL	TDRD15 GAS6 SIK3 CELSR2	9.51e-04	54	238	4	EFO_0022153
Disease	triglycerides in medium VLDL measurement	TDRD15 SIK3 INTS10 CELSR2	1.02e-03	55	238	4	EFO_0022155
Disease	cholesterol to total lipids in large HDL percentage	SIK3 INTS10 CELSR2 NUP93	1.02e-03	55	238	4	EFO_0022234
Disease	Fanconi Anemia	ERCC1 BRCA2 RFWD3	1.05e-03	25	238	3	C0015625
Disease	apolipoprotein B measurement	ANKRD31 TDRD15 ERCC1 GAS6 NAGS BRCA2 KCNK17 UQCRHL BRWD1 AMHR2 SIK3 CELSR2 NUP93 DNAH11	1.06e-03	663	238	14	EFO_0004615
Disease	triglycerides in LDL measurement	TDRD15 GAS6 SIK3 CELSR2	1.09e-03	56	238	4	EFO_0022320
Disease	cholesterol to total lipids in large LDL percentage	TDRD15 SIK3 CELSR2 NUP93	1.09e-03	56	238	4	EFO_0022235
Disease	free cholesterol to total lipids in medium VLDL percentage	ANKRD31 TDRD15 SIK3 CELSR2	1.17e-03	57	238	4	EFO_0022284
Disease	cholesteryl ester measurement	ANKRD31 TDRD15 GAS6 YDJC SIK3 INTS10 CELSR2 NUP93	1.21e-03	257	238	8	EFO_0010351
Disease	triglycerides in IDL measurement	TDRD15 GAS6 SIK3 CELSR2	1.24e-03	58	238	4	EFO_0022149
Disease	triglycerides to total lipids in small VLDL percentage	ANKRD31 TDRD15 SIK3 CELSR2	1.24e-03	58	238	4	EFO_0022338
Disease	low density lipoprotein cholesterol measurement, alcohol consumption measurement	TDRD15 GAS6 RAB3GAP1 CELSR2 DNAH11	1.26e-03	99	238	5	EFO_0004611, EFO_0007878
Disease	very low density lipoprotein cholesterol measurement	ANKRD31 TDRD15 GAS6 BRWD1 SIK3 INTS10 CELSR2 DNAH11	1.30e-03	260	238	8	EFO_0008317
Disease	fish oil supplement exposure measurement, high density lipoprotein cholesterol measurement	SIK3 INTS10	1.32e-03	7	238	2	EFO_0004612, EFO_0600007
Disease	laurylcarnitine measurement	AK5 ABCC1	1.32e-03	7	238	2	EFO_0021041
Disease	infertility (implicated_via_orthology)	BRCA2 CSF1R	1.32e-03	7	238	2	DOID:5223 (implicated_via_orthology)
Disease	endometrial adenocarcinoma (is_implicated_in)	AXIN2 PIK3R1	1.32e-03	7	238	2	DOID:2870 (is_implicated_in)
Disease	cholesterol in medium HDL measurement	YDJC SIK3 INTS10 CELSR2	1.33e-03	59	238	4	EFO_0021903
Disease	Acute kidney injury	GAS6 NFE2L2 TLR4 CD44 LRP2	1.38e-03	101	238	5	C2609414
Disease	Acute Kidney Insufficiency	GAS6 NFE2L2 TLR4 CD44 LRP2	1.38e-03	101	238	5	C1565662
Disease	Kidney Failure, Acute	GAS6 NFE2L2 TLR4 CD44 LRP2	1.38e-03	101	238	5	C0022660
Disease	obsolete_red blood cell distribution width	IRF2BP1 GAS6 RGPD1 CDH23 ITGAX PLEKHG5 DOCK5 PIK3R1 AFDN YDJC ATP11C USP47 ABCC1 TRIM58 BAZ2B RBL1 NVL TRMT1 SIK3 INTS10 KANSL1 HELZ2	1.42e-03	1347	238	22	EFO_0005192
Disease	low density lipoprotein cholesterol measurement, alcohol drinking	TDRD15 GAS6 RAB3GAP1 CELSR2 DNAH11	1.44e-03	102	238	5	EFO_0004329, EFO_0004611
Disease	glucose metabolism disease (implicated_via_orthology)	PIK3CD DIO2 TLR4	1.46e-03	28	238	3	DOID:4194 (implicated_via_orthology)
Disease	free cholesterol in very large VLDL measurement	ANKRD31 TDRD15 SIK3 INTS10	1.50e-03	61	238	4	EFO_0022274
Disease	free cholesterol in VLDL measurement	TDRD15 GAS6 SIK3 CELSR2	1.50e-03	61	238	4	EFO_0022276
Disease	cancer (implicated_via_orthology)	CAND2 AXIN2 BRCA2 PIK3CD RBL1 CSF1R FRMD6 PROX2	1.58e-03	268	238	8	DOID:162 (implicated_via_orthology)
Disease	triglycerides in medium LDL measurement	TDRD15 GAS6 SIK3 CELSR2	1.60e-03	62	238	4	EFO_0022322
Disease	cutaneous melanoma, hair color	ADD3 HERC2 TPCN2 MED13L	1.60e-03	62	238	4	EFO_0000389, EFO_0003924
Disease	type 2 diabetes mellitus (implicated_via_orthology)	ALMS1 ADAMTS9 PIK3CD ATP2A2 PCK1	1.64e-03	105	238	5	DOID:9352 (implicated_via_orthology)
Disease	breast carcinoma	SPTBN2 ADD3 BRCA2 PIK3R1 ATXN10 KLHL18 CCDC170 TPCN2 ARHGEF5 ARHGEF12 SIK3 KHDC4 INTS10 KANSL1 DNM3 AP4B1 LRRD1 DNAH11	1.65e-03	1019	238	18	EFO_0000305
Disease	urate measurement, bone density	ATP6V1B1 ERC1 HCN2 DOCK5 RHOBTB1 GBP5 BAZ2B SCYL2 HEATR6 HELZ2 KIAA1755 DNAH11 EPHB1	1.67e-03	619	238	13	EFO_0003923, EFO_0004531
Disease	triglycerides to total lipids in medium VLDL percentage	ANKRD31 TDRD15 SIK3 CELSR2	1.69e-03	63	238	4	EFO_0022335
Disease	cholesterol to total lipids in medium VLDL percentage	ANKRD31 TDRD15 SIK3 CELSR2	1.69e-03	63	238	4	EFO_0022239
Disease	familial hyperlipidemia	TDRD15 ERCC1 GAS6 INTS10 CELSR2	1.71e-03	106	238	5	MONDO_0001336
Disease	esterified cholesterol measurement, intermediate density lipoprotein measurement	TDRD15 CELSR2	1.76e-03	8	238	2	EFO_0008589, EFO_0008595
Disease	Ventricular Dysfunction, Left	NFE2L2 TLR4 ATP2A2	1.79e-03	30	238	3	C0242698
Disease	triglycerides in small LDL measurement	TDRD15 GAS6 SIK3 CELSR2	1.90e-03	65	238	4	EFO_0022323
Disease	cholesterol in very large VLDL measurement	TDRD15 SIK3 INTS10 CELSR2	1.90e-03	65	238	4	EFO_0022230
Disease	low density lipoprotein cholesterol measurement, physical activity	TDRD15 PFAS CELSR2 DNAH11	2.01e-03	66	238	4	EFO_0003940, EFO_0004611
Disease	non-alcoholic fatty liver disease, type 2 diabetes mellitus	BCKDHB RICTOR MON1B DNM3 VPS53	2.02e-03	110	238	5	EFO_0003095, MONDO_0005148
Disease	triglyceride measurement, intermediate density lipoprotein measurement	GAS6 BRCA2 BRWD1 INTS10 CELSR2	2.10e-03	111	238	5	EFO_0004530, EFO_0008595
Disease	total lipids in large VLDL	TDRD15 SIK3 INTS10 CELSR2	2.13e-03	67	238	4	EFO_0022175
Disease	squamous cell carcinoma	BRCA2 HERC2 TPCN2 DNAH11	2.13e-03	67	238	4	EFO_0000707
Disease	MYELODYSPLASTIC SYNDROME	ATRX BRCA2 SMPD3 CSF1R	2.13e-03	67	238	4	C3463824
Disease	Benign Neoplasm	ERCC1 CSF1R LTF MSLN	2.24e-03	68	238	4	C0086692
Disease	Neoplasms	ERCC1 CSF1R LTF MSLN	2.24e-03	68	238	4	C0027651
Disease	Osteitis Deformans	NUP205 PML	2.25e-03	9	238	2	C0029401
Disease	glucose metabolism decline measurement, cingulate cortex measurement	CDH23 VPS53	2.25e-03	9	238	2	EFO_0007738, EFO_0009392
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	ANKRD31 TDRD15 IRF2BP1 INTS10 CELSR2 HELZ2 NUP93	2.25e-03	222	238	7	EFO_0008317, EFO_0020943
Disease	Schizophrenia	GABRB1 GABRB3 SPTBN2 TRRAP CHRM5 STXBP1 GLUL PML FZD3 GRIN2D TLR4 LRP2 ARHGAP18 ATP2A2 MCTP2 PCK1	2.31e-03	883	238	16	C0036341
Disease	triglyceride measurement, low density lipoprotein cholesterol measurement	TDRD15 GAS6 BRCA2 BRWD1 INTS10 CELSR2	2.35e-03	166	238	6	EFO_0004530, EFO_0004611
Disease	low density lipoprotein cholesterol measurement, lipid measurement	TDRD15 GAS6 BRCA2 BRWD1 CELSR2	2.36e-03	114	238	5	EFO_0004529, EFO_0004611
Disease	intracranial volume measurement	CCNG2 KANSL1 ATP2A2	2.36e-03	33	238	3	EFO_0004886
Disease	total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer	ANKRD31 TDRD15 SIK3 CELSR2	2.37e-03	69	238	4	EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992
Disease	4-vinylphenol sulfate measurement	GABRB3 EPHB1	2.79e-03	10	238	2	EFO_0021149
Disease	otitis media (is_marker_for)	MUC5B TLR4	2.79e-03	10	238	2	DOID:10754 (is_marker_for)
Disease	Fanconi anemia (is_implicated_in)	BRCA2 RFWD3	2.79e-03	10	238	2	DOID:13636 (is_implicated_in)
Disease	COVID-19 symptoms measurement	MUC5B KANSL1 LTF	2.80e-03	35	238	3	EFO_0600019
Disease	endometrial cancer (is_implicated_in)	BRCA2 PIK3CD PIK3R1	3.04e-03	36	238	3	DOID:1380 (is_implicated_in)
Disease	cholesteryl esters to total lipids in very large HDL percentage	TDRD15 SIK3 CELSR2	3.04e-03	36	238	3	EFO_0022257
Disease	cutaneous melanoma	ADD3 FMN1 HERC2 TPCN2 MED13L	3.05e-03	121	238	5	EFO_0000389
Disease	creatinine measurement	ATP6V1B1 CAND2 OBSCN ALMS1 NFE2L2 PIK3R1 NPHS1 VIL1 TPCN2 ATP6V1G1 CUBN RFWD3 CELSR3 CELSR2 LRP2 KIAA1755 PCK1	3.11e-03	995	238	17	EFO_0004518
Disease	hepatocellular carcinoma (is_marker_for)	ERCC1 PFAS NUF2 AXIN2 PML RICTOR CSF1R TLR4	3.22e-03	301	238	8	DOID:684 (is_marker_for)
Disease	colorectal carcinoma (is_marker_for)	AXIN2 BRCA2 CSF1R	3.29e-03	37	238	3	DOID:0080199 (is_marker_for)
Disease	pigmentation disease (is_implicated_in)	HERC2 TPCN2	3.40e-03	11	238	2	DOID:10123 (is_implicated_in)
Disease	heart disease (implicated_via_orthology)	PIK3CD KCNK17 ATP2A2	3.55e-03	38	238	3	DOID:114 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
PQLSDCEAAFVNRDL	ACCSL	121	Q4AC99
EIILDDDECPLQIFR	AFDN	316	P55196
IVEFCHPEDQQLLRD	ARNT	396	P27540
DFRCALLASEVPQLA	BRAT1	536	Q6PJG6
ELEEEFCRLRPLLSQ	ARHGEF1	886	Q92888
ESFLETLLQNDVCLP	ANKRD30B	731	Q9BXX2
NRLQILTEVAADRPC	CASS4	66	Q9NQ75
LDQIVESCLLPELNV	AZIN1	361	O14977
ILQSPAFREDLECLI	ADD3	61	Q9UEY8
VELACRDPSQVENLA	ATXN10	61	Q9UBB4
ACVLLSQSRLFEEPE	BTBD6	241	Q96KE9
QDLLVRLLSAAVCDP	BAZ2B	1136	Q9UIF8
REELDLLECYNSPQV	ARHGEF5	1501	Q12774
FNLTENERPLAVCEN	GRAMD4	451	Q6IC98
ENRQICAFSDVLPVL	AAR2	151	Q9Y312
NRDLFCSPLLVIQDS	ALMS1	206	Q8TCU4
LPSCIFLEQRELFEQ	ALMS1	2876	Q8TCU4
FLLAARIVEEDCNIP	CCNG2	106	Q16589
ELPCVENLNSIELNR	ANKRD18B	956	A2A2Z9
SLLRDQDPIVVVNCL	AP4B1	166	Q9Y6B7
IQCLQETEFPQTRIL	DNAH11	346	Q96DT5
PNTLAQLEEACRRLA	AXIN2	691	Q9Y2T1
EVIAQLPEAFLVSCE	AADACL4	331	Q5VUY2
LPEAFLVSCENDILR	AADACL4	336	Q5VUY2
CLQEPSDLRAVLLIN	ARMC3	591	Q5W041
TQRVLPFDDNICLRE	CELSR1	1296	Q9NYQ6
AQRVLPFDDNICLRE	CELSR2	1221	Q9HCU4
LTCPEAQLLEAQALE	AHDC1	251	Q5TGY3
RCNFPNVEIVTIAEA	BCOR	1681	Q6W2J9
VIQVLDVNDCRPQFS	CDH23	2496	Q9H251
SCIAENLVPNLFLEL	CDAN1	311	Q8IWY9
NDLCVDPTEFRVLLL	DCUN1D3	116	Q8IWE4
CVELLLSRNADPNVA	ASZ1	131	Q8WWH4
ELQELPELCFSQVIR	AMHR2	196	Q16671
DPEARLTAECVQQRL	AMHR2	491	Q16671
PQQDFEALLAECLRN	CAPN14	26	A8MX76
FVQDAESNPLCRRLQ	ARHGEF12	911	Q9NZN5
EDVPNDRCSALLELQ	C17orf113	141	A0A1B0GUU1
LQPNLVDLCASVAEL	NUP93	201	Q8N1F7
PLRELGQVVECSLDF	MUC5B	2926	Q9HC84
PLRELGQVVECSLDF	MUC5B	3626	Q9HC84
RELSVQLQPTDALLC	RAVER1	121	Q8IY67
DLERFVSCLLEQPEV	RAB3GAP1	866	Q15042
EPCVAELTEENFQRL	ERC1	256	Q8IUD2
AVREFLENNAELCQP	PCK1	26	P35558
LVDPLTTVREQCEQL	UQCRHL	26	A0A096LP55
LVDPLTTVREQCEQL	UQCRH	26	P07919
LLQDLQTDQPVLDIC	RFWD3	736	Q6PCD5
LAQIPNFAERAQCII	FMN1	1131	Q68DA7
SRQECPRQEQDIVFL	ITGAX	141	P20702
LRELFEQAVSNAPCI	NVL	346	O15381
NAPCIIFIDEIDAIT	NVL	356	O15381
DCEFLVQRARELVPQ	INTS10	6	Q9NVR2
ACPQDLIQAEDRQLI	NUP205	1296	Q92621
RCELQLEAVVENPLN	PCDHGB6	101	Q9Y5F9
RCELQLEAVVENPLN	PCDHGB7	101	Q9Y5F8
CAPREEDFDQLLEAL	PALD1	631	Q9ULE6
QLASIPRELCFLENL	LRRC69	141	Q6ZNQ3
PRELCFLENLVELQL	LRRC69	146	Q6ZNQ3
RTVDLIPVDQFRNVC	LRRC9	1106	Q6ZRR7
TLERNLCISQDVEFP	ZFYVE28	281	Q9HCC9
LCISQDVEFPIRADV	ZFYVE28	286	Q9HCC9
RNVLAECRLDPADLQ	MON1B	291	Q7L1V2
LQEAEIACLVPVDQF	RNF144B	86	Q7Z419
LPIFRCLNSLERNIE	RAD9B	91	Q6WBX8
INEILLISDQEFLPC	ANKRD31	1841	Q8N7Z5
RAIDENNEPTACFLI	ANKFY1	731	Q9P2R3
QEECFLNLEAPISRV	BCKDHB	346	P21953
NVEFVPRQLGLTECR	EPHB1	376	P54762
DLSQLIIRNCPSFDI	FASTK	141	Q14296
NRQLLVCEASSPALE	NPHS1	211	O60500
IFVDAPLNICESRDV	PAPSS2	146	O95340
CQQPAVIFIDEIDSL	FIGNL1	491	Q6PIW4
RCAAAQQLLERFSLP	DIO2	191	Q92813
FPRELCTLENLQVLD	LRRD1	571	A4D1F6
FCNPSVLDRLNALLE	MDN1	2246	Q9NU22
EDQQCLVFRDVAPQA	HINT2	71	Q9BX68
RTRACDLLLQPDNLA	IL17RD	181	Q8NFM7
DPFCLLELGNDRLQT	MCTP2	531	Q6DN12
AQDDPILLSFIRCLQ	MED13L	51	Q71F56
VRIQICPFENDTEAL	IL17REL	191	Q6ZVW7
PRDVAQALSFEDQIC	AK5	221	Q9Y6K8
TPDLVVFLACANQRL	AK5	236	Q9Y6K8
LFNELRPAVCNDLSI	HERC2	1516	O95714
FVDDRPQVVNALCQA	KIAA1755	186	Q5JYT7
ELCSLNQEDFFQRVP	GABPA	221	Q06546
RCRALEEELENPLNV	CFAP58	696	Q5T655
GNQFQCDDLIIRPLE	MED7	46	O43513
PEFQLICTNLDELRE	KIAA2026	761	Q5HYC2
VNRDICDLPQELSNL	LRRC39	161	Q96DD0
RTLAEICLNTEIEPF	DSG4	841	Q86SJ6
RENCLILAVTPANTD	DNM3	166	Q9UQ16
EQLIAASREDLALCP	ERCC1	261	P07992
CLFQDVDERAVPLLG	PER2	341	O15055
DEPQRFAADLLQCVQ	PLXNA1	551	Q9UIW2
LCAFPLDEVDRLANR	PLXNB1	321	O43157
ELLQNFTCLDRPALD	KCNK17	61	Q96T54
AAARAPEQVQRLIFC	OGDHL	876	Q9ULD0
LPICRVNDFETADIL	NUF2	96	Q9BZD4
ENECFFELEVVILPN	PCDH9	106	Q9HC56
LLSIPELQCLNIEND	NFE2L2	191	Q16236
AVVPFVILQCQRDSE	FAM209B	66	Q5JX69
APEDVSALLVQACRL	HEATR6	71	Q6AI08
EVEEQCRQLGLPLAA	PDZD3	301	Q86UT5
EAPLLERLSQLDSCV	KANSL1	651	Q7Z3B3
QGLEPVFEACLDQLR	KRT78	156	Q8N1N4
DLPCIENAVLALAQR	GBP5	306	Q96PP8
RRYPLDEQNCTLEIE	GABRB1	166	P18505
TEAAAVALIQDCRLP	GDPGP1	351	Q6ZNW5
RRYPLDEQNCTLEIE	GABRB3	166	P28472
QDLDTCDPRQLDVLY	MSLN	471	Q13421
ELSLRPCVENEFVAL	KRT82	211	Q9NSB4
RQVENLLDLPCLQFL	LRRC46	101	Q96FV0
VLSNVNLPADLDLVC	NAGS	306	Q8N159
DLLNCLRDDQPFLIT	LRP2	1736	P98164
QQPEAALLRCDQALE	LONRF2	211	Q1L5Z9
QIFLEDFCSPRQVAE	ARMC7	161	Q9H6L4
SNLAELRQLLDCDTP	PIK3R1	156	P27986
VCLLPDSLARVNNLF	SMPD3	131	Q9NY59
ELLLQQFSSRCEAPD	GOLGA2	346	Q08379
LRPDCDTQVELQFQL	HELZ	581	P42694
ICELALQNPEVVALR	RICTOR	191	Q6R327
DCLTLIPAFSREQEQ	NDOR1	506	Q9UHB4
EPRLQGCTAELVLQD	OBSCN	3936	Q5VST9
RDSCQLVLVESIPQD	PLD4	91	Q96BZ4
EVPDCFLEIASLTLQ	PROX2	536	Q3B8N5
RQADFVQVLSCVLDP	COG6	466	Q9Y2V7
LQFEDRFDIEVTPNC	CUBN	2261	O60494
RALPRNSILVCAEEQ	GASK1A	81	Q9UFP1
LSFLCEIRQTPEFEQ	FRMD3	556	A2A2Y4
RSVCIFLPNDESLNI	FRMD6	16	Q96NE9
EFDELNPSAQRDACL	ATP2A2	656	P16615
EPLLDLVTACNSVFE	ATRX	271	P46100
LVVCQRSNGERFPDL	ADAMTS9	1406	Q9P2N4
VVFEDQDALLPCLLT	CSF1R	116	P07333
QERFNIICDLLELSP	ESPL1	601	Q14674
PENAEFLTALCELRL	IFIT5	466	Q13325
LCRPQFLSDRVQQDD	KLHL18	231	O94889
VRLALLPSDCLQEAV	KLHL25	236	Q9H0H3
DTCPLAQEEILEINR	KCNC1	486	P48547
EIRDIQTINPLDVLC	CARD6	366	Q9BX69
QSECREVLLPLLTDQ	DOCK5	871	Q9H7D0
EFANRCLSPERVLLQ	BRCA2	2641	P51587
PLSLAQIDLNITCRF	CD44	16	P16070
DDQELIIPCLALVRA	CCNDBP1	236	O95273
DLPFRIQSCAAQAVL	FRMPD3	846	Q5JV73
ECALAALLPAREATQ	GAS6	26	Q14393
QARLFDEPQLASLCL	BTBD1	186	Q9H0C5
FLNCITIALERPQIE	CACNA1I	1181	Q9P0X4
ISRIEAVLPQCDLNN	FASTKD1	436	Q53R41
PVECLRENIAFELPQ	IFNK	56	Q9P0W0
DCALVQTLPIEEREN	COL22A1	381	Q8NFW1
VNLIFQCEDSEPFRQ	BRWD1	1326	Q9NSI6
QARCRPNADLELNDV	CDC42EP5	131	Q6NZY7
LDSIENLPCELQRNF	ING5	11	Q8WYH8
DELCFLEQRPQSPTL	EDARADD	151	Q8WWZ3
FLLEDRVACNASIPA	FZD3	256	Q9NPG1
EVEINDVPLTCRNLL	KHDC4	106	Q7Z7F0
DCPLIVQFAANDARL	DUS4L	81	O95620
IFRCIEPELNNLIAL	EXOC1	586	Q9NV70
FLLPQNECELHDFRL	GDF9	346	O60383
FLTQLRDCLDPDERN	CCDC170	171	Q8IYT3
VCDNLLNVPDDILQL	DPEP3	296	Q9H4B8
RQIPRLNNLICDESD	ELP4	351	Q96EB1
RSLLDVLPFDDNVCL	CELSR3	1366	Q9NYQ7
RSLLDFCEAQQTLVP	HELZ2	2621	Q9BYK8
LFDEPQLASLCLENI	BTBD2	231	Q9BX70
LDRLVPLVEDFCNLD	CAND2	256	O75155
LIFERALVENCLVPD	SART3	331	Q15020
PARQILVLDNAAIVC	SCAP	1246	Q12770
ELNGPLREEIVNFNC	HCN2	521	Q9UL51
LCDLLASAADPQIRQ	IPO4	41	Q8TEX9
VQCEQTDRFNVFLLP	DOK4	131	Q8TEW6
IPTVCEELFRAIENQ	KIF28P	131	B7ZC32
EQLLALSACAPFNVR	IRF2BP1	231	Q8IU81
ELQNCELERIPHAIF	LRRC8D	641	Q7L1W4
CSGEEQNLFPLEINR	PRDM2	106	Q13029
EPLNTLQRLCEELEY	OSBPL3	551	Q9H4L5
NEPLNTLQRLCEELE	OSBPL7	501	Q9BZF2
QQVREICISRDFLPG	PIAS2	186	O75928
NAPESICILDLEVFL	RGPD1	466	P0DJD0
SLRENILFGCQLEEP	ABCC1	721	P33527
IRTCLLNETGDEPFQ	GLUL	356	P15104
LLEQCESFIPVLQDT	RTL3	301	Q8N8U3
LNRFLQVLPACTEDE	RTTN	1126	Q86VV8
VTLLDRLDCDQINLP	UPP2	276	O95045
VCLFLNLANDPTIER	ATP6V1B1	251	P15313
NAAIRDCDRAIEINP	ST13P4	161	Q8IZP2
LCSREVPLIQIETDQ	SPHKAP	1421	Q2M3C7
PVQEFNRDLTCAVIT	TRMT1	76	Q9NXH9
TCLEQLEPFSVVDIR	TRIM45	51	Q9H8W5
CAALPRDFIDQVVLQ	TRMT44	601	Q8IYL2
CRQLEAASLQAIPTE	SMYD4	451	Q8IYR2
LQTCRDLPALRDELF	PLEKHH3	291	Q7Z736
PIQCIQAIAENRADA	LTF	61	P02788
LSCILAQQPDRLRDE	TRADD	136	Q15628
LCAINPRFLLLESQA	TDRD15	846	B5MCY1
QLINIFESCVRNPVE	RBL1	411	P28749
FEECQRLLLDIPLQT	RGPD2	1156	P0DJD1
LCRLRQEEPQSLQAA	PML	356	P29590
SQTPNEECLFLERLE	FGF1	91	P05230
DADPNFDRLIAECQQ	SIK3	321	Q9Y2K2
VIRCNLAPVVEFAAD	ST8SIA4	166	Q92187
LEAAVRQACAPQELE	SHROOM1	686	Q2M3G4
ELCLNIIPTFANLID	SCYL2	466	Q6P3W7
DNPLCADVLFILQDQ	RHOBTB1	261	O94844
FTPLQLQELECIFQR	RHOXF2B	141	P0C7M4
LQELECIFQREQFPS	RHOXF2B	146	P0C7M4
NPILERLAEQIATLC	STXBP1	166	P61764
CTAAPTNRQIEILEL	NUP160	1166	Q12769
ALLAENPARTAQDCL	PNMA6A	211	P0CW24
RTVPLDECQIQFLSE	CHRM5	176	P08912
EVQADETFPCDLILL	ATP11C	151	Q8NB49
PVRLQLCDTAGQDEF	RHOU	96	Q7L0Q8
GQVVDCSRLFDNDLP	SMURF2	146	Q9HAU4
QVNAILPALSRCFEL	PRAMEF6	366	Q5VXH4
EVAAEFLNDRVPNCN	UBA3	126	Q8TBC4
CEVEAERLFSNIPEI	PLEKHG5	376	O94827
LPSFRAIQDDCQVIT	VPS51	216	Q9UID3
QEENLVITPRLFECS	VIL1	611	P09327
RVLDPLLCDFLDSQD	TBC1D17	471	Q9HA65
CPVRTSLDLELDLQA	WWC2	1061	Q6AWC2
RPFDLTLCELSQPDQ	RNASE10	171	Q5GAN6
VTRDQADPQCLFLRQ	SPTBN2	1131	O15020
ADPQCLFLRQRLEAL	SPTBN2	1136	O15020
PTGNCDLERFAQVLE	SLC27A4	556	Q6P1M0
CAPSNIAVDNLVERL	IGHMBP2	241	P38935
NCNLALVELQPDRGE	SPINT1	96	O43278
NTPCVLDLQRALVQD	STYXL2	111	Q5VZP5
FQLDRLQAEPRCVAE	PFAS	1016	O15067
LEAARQPLEREQCLA	USP35	26	Q9P2H5
FEFCDSLQQIVIPER	nan	66	Q6ZSR6
QVNAILPALSRCFEL	PRAMEF5	366	Q5TYX0
VNACILPLLQIDRDS	TRPV2	131	Q9Y5S1
CPTVQLEDIRNLQDL	TRPV2	281	Q9Y5S1
FLQIENAAEEPRVLC	USP47	31	Q96K76
NAAEEPRVLCIIQDT	USP47	36	Q96K76
LLQDFRDQNIPGCES	TTMP	191	Q5BVD1
LDNLLAFVCDIRPEI	ATP6V1G1	96	O75348
LPQVREELEAQLSCF	YDJC	106	A8MPS7
ELEDEQRRLCDVQPF	PIK3CD	81	O00329
ECIRLRPESALAQAQ	TOMM70	426	O94826
DLELFTPGNLERECN	PRRG4	56	Q9BZD6
SPDQGDDLENCILRF	TSTD2	6	Q5T7W7
RTLLDLCQIQDFPSQ	TMEM82	306	A0PJX8
QSILQRCLELDPASV	TTC21A	521	Q8NDW8
NVLRDACLVANILDP	VPS53	236	Q5VIR6
SIQLLVQDLDAACDP	VPS53	601	Q5VIR6
EQRLFQPDLCDVDLV	ZBTB47	6	Q9UFB7
LFCVPLTALLEQDQR	ARHGAP18	321	Q8N392
RALALNCFAPINDQE	UHRF1	506	Q96T88
NPREECVSAQTLLLQ	ZZEF1	781	O43149
LNDPSLVCIRSDFNE	TMEM117	461	Q9H0C3
LLQEIALSEPQLCEV	ZC3HAV1	26	Q7Z2W4
EELVEPFRCDSQLIQ	ZNF23	171	P17027
ALQELNRCPFRVVDE	SMC5	1006	Q8IY18
SFPELQVLDLSRCEI	TLR4	76	O00206
RENPDLACLQSIIFD	TTC4	56	O95801
LACLQSIIFDEERSP	TTC4	61	O95801
LLQQDRCLARPQESA	VGLL1	171	Q99990
QVARECERLLEQFPL	ZFYVE26	1351	Q68DK2
LRTLELCVDNLQPDF	TRRAP	846	Q9Y4A5
AQAEPINLDSCLRAF	USP6	1026	P35125
PAERDDFILGILNCV	TPCN2	461	Q8NHX9
ELADELQERCQRPAL	TRIM58	231	Q8NG06
RDSQRAPEAVLCLQL	WDR36	11	Q8NI36
VPIDDLCQFLIVATN	PP2D1	441	A8MPX8
SIPQLCNENRVLRED	PDE4DIP	1896	Q5VU43
LLPEEAQRCGTVLDQ	MZF1	211	P28698
AQIRLLFCAREEAEP	GRIN2D	241	O15399